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SUMMARY 
 
Background. Acute pancreatitis (AP) is a potentially fatal disease characterized by local 
complications and/or systemic organ failure. Recent investigations suggest that pancreatic 
ductal epithelial cells (PDECs) help to protect the pancreas from noxious agents, such as 
alcohol or premature trypsinogen activation in the early phase of the disease. Since the 
cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel plays a major 
role in PDEC physiology our aims in this study were to investigate the direct effects of (i) 
ethanol (EtOH) and its metabolites and (ii) trypsin on CFTR activity.  
Methods. Human ductal adenocarcinoma cell line (Capan-1) and guinea pig PDECs were 
used. We investigated the effects of EtOH (1, 10 and 100 mM), palmitoleic acid (POA; 10, 
100 and 200 µM), palmitoleic acid ethyl ester (POAEE; 10, 100 and 200 µM) and trypsin 
(10 µM) on CFTR Cl- currents using the whole cell configuration of the patch clamp 
technique. Changes in intracellular ATP (ATPi) were estimated by the Mg2+-sensitive 
fluorescent dye, Magnesium Green-AM (MgGreen-AM). 
Results and Conclusions. In the first part of this thesis we tested the hypothesis that EtOH 
exerts a direct effect on CFTR to impair ductal function. Administrations of low 
concentration of EtOH (1 mM) had no significant effect on isolated PDECs either on basal 
or forskolin-stimulated CFTR currents. However, at higher concentrations such as 10 or 
100 mM EtOH increased the basal and decreased the forskolin-stimulated CFTR currents. 
Using equivalent concentration of mannitol, we showed that the stimulatory effect of EtOH 
is a non-specific, osmotic effect; whereas the inhibitory effect of EtOH is independent of 
its osmotic effect. The unsaturated fatty acid, POA and its esterized form POAEE, 
reversibly and time-dependently inhibited CFTR currents at higher concentrations (100 and 
200 µM). Both EtOH, POA and POAEE significantly decreased the level of ATPi in the 
ductal cells, whereas administration of ATPi back to the cell via the patch pipette almost 
completely abolished the inhibitory effect of EtOH and its metabolites on CFTR. In 
summary, our results show that high concentration of EtOH, POA and POAEE strongly 
inhibit CFTR Cl- channel in the ductal cells through the depletion of ATPi. We speculate 
that restoration of the intracellular energetic pool by ATP supplementation may represent a 
novel therapeutic tool for the treatment of alcohol-induced pancreatitis. 
In the second part of the thesis we showed, that both trypsin and proteinase-
activated receptor-2 (PAR-2) activating peptide (PAR-2-AP) irreversibly decreased 
forskolin-stimulated CFTR Cl- current in PDECs. Pretreatment with either soybean trypsin 
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inhibitor (SBTI) or PAR-2 antagonist (PAR-2-ANT) completely prevented the inhibitory 
effect of trypsin. In summary, these data suggests , that trypsin inhibits CFTR Cl- currents 
by activation of PAR-2, which might have an important role in the pathogenesis of chronic 
pancreatitis. 
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1. INTRODUCTION 
 
The exocrine pancreas consist of two main cell types: the acinar and the ductal 
cells. The digestive enzymes are synthetized and secreted by the acinar cells, whereas the 
ductal cells secrete a bicarbonate-rich isotonic solution which is essential for the transport 
of digestive enzymes into the duodenum, and insures an optimal pH environment for the 
action of digestive enzymes.1, 2 Ductal HCO3- secretion is not only regulated by 
gastrointestinal hormones and cholinergic nerves but is influenced by luminal factors, 
intraductal pressure, Ca2+ concentration, or pathological activation of proteases. The 
human pancreatic ductal system secretes about 2 litres of pancreatic juice per day, which 
containing as much as 140 mmol/l HCO3- at maximal stimulation.3 Previous studies 
indicated that reduced or deficient fluid and HCO3- secretion leads to the destruction of the 
pancreas, and causes different pancreatic diseases, such as cystic fibrosis.4, 5 
PDECs possess several transporters and ion channels, which play a crucial role in 
HCO3- secretion (Fig. 1). 
 
 
 
Fig. 1. Cellular mechanism of pancreatic ductal HCO3- secretion. Intracellular HCO3- is derived from CO2 through 
the action of  carbonic anhydrase. Redundant H+ than leaves the cell through the Na+/H+ exchanger and the proton pump. 
The alternative pathway involves the direct uptake of  HCO3- from the blood by the Na+/HCO3- cotransporter. HCO3- than 
leaves the cells through the Slc26 Cl-/HCO3- exchanger and the CFTR Cl- channel at the apical membrane. CA: carbonic 
anhydrase, CFTR: cystic fibrosis transmembrane conductance regulator, Slc26: solute carrier family 26,CACC: calcium -
activated chloride channel . 
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It is now generally accepted that accumulation of HCO3- across the basolateral membrane 
is achieved by passive diffusion of CO2, its hydration and dissociation to H+ and HCO3- 
ions. Other mechanism for HCO3- uptake is based on the aligned function of the 
Na+/HCO3- cotransporter, the Na+/H+ exchanger and the H+-ATPase.1, 6 In contrast, HCO3- 
secretion at the apical membrane is driven by the CFTR Cl- channel, the Cl-/HCO3- 
exchanger and calcium–actvated chloride channel (Fig. 1).2, 7, 8  
The CFTR protein is a cAMP-regulated Cl- channel with multiple functions in 
epithelial cells (Fig. 2).9 In the exocrine pancreas the CFTR plays a key role in the apical 
Cl-, HCO3- and water transport in PDECs. The severe loss of functions, caused by 
mutations of the CFTR gene, leads to pathological lesions of the pancreas. The 
characteristic behavior of CFTR is determined by the function of the different domains 
from which CFTR is assembled. These include the two membrane-spanning domains 
(MSDs) that are each composed of six transmembrane segments, the two nucleotide-
binding domains (NBDs) that each contain motifs which interact with ATP, and the unique 
R (regulatory) domain that contains multiple consensus phosphorylation sites for protein 
kinase A (PKA) and protein kinase C (PKC) moreover many charged amino acids.  
 
 
 
Fig. 2. Model showing proposed domain structure of cystic fibrosis transmembrane conductance regulator 
(CFTR). MSD: membrane-spanning domain; NBD: nucleotide-binding domain; R: regulatory domain; PKA: cAMP-
dependent protein kinase. 
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The MSDs assemble to form the Cl- selective pore while the NBDs and R domain control 
CFTR channel gating.10, 11 The classical view is that CFTR mainly secretes Cl- and having 
a relatively low permeability to HCO3-. However, under stimulated secretion the channel 
permeability changes and become more permeable for HCO3- than Cl-.2, 12 It is well 
documented that insuffiecient function of CFTR increases the risk of AP.13  
AP is a sudden and severe disease characterized by local complications and/or 
systemic organ failure. Heavy alcohol consumption is one of the leading causes of AP,14, 15 
however, the cellular mechanism by which EtOH induces pancreatitis is not well 
understood. EtOH can be metabolized by two different pathways: the oxidative and the 
nonoxidative pathways. The oxidative pathway involves alcohol dehydrogenase, which 
enzyme catalyse EtOH conversion to acetaldehyde (Ac). Ac than further oxidized by Ac 
dehydrogenaze to acetate. This conversion happens dominantly in the liver. In contrast, the 
non-oxidative metabolism of EtOH involves the esterification of EtOH with fatty acids 
(FAs) and the production of fatty acid ethyl esters (FAEEs).16 The formation of FAEEs 
from EtOH and FAs is catalysed by the enzyme, FAEE synthase,17 whereas FAEE 
hydrolase is responsible for the reverse reaction. The effects of EtOH or its metabolites on 
the pancreas were mainly investigated on acinar and stellate cells whereas much less 
studies have been done on PDECs. Yamamoto et al. showed that low concentrations (0.3–
30mM) of EtOH augmented ductal fluid secretion stimulated with physiological or 
pharmacological concentrations of secretin, whereas a high concentration of EtOH (100 
mM) completely abolished this effect.18 However, no data is available regarding the effect 
of EtOH or its metabolites on the activity of CFTR Cl- channel. 
The possible role of CFTR in the pathomechanism of alcoholic pancreatitis has 
been first raised due to Henry Sarles.19 He investigated 205 patients with different form of 
pancreatitis. Almost all of his patient were alcoholics. In 100 patients, he observed the 
presence of protein plugs in the intra/interlobular pancreatic ducts and these patients 
secreted significantly higher Cl- and Na+ compare to controls. These results clearly suggest 
that the CFTR Cl- channel did not work properly in these patients. Therefore, our main aim 
in this study was to characterize the direct effects of EtOH, FA and FAEE on PDECs, 
especially on CFTR channel activity.  
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It is generally accepted that inappropriate or premature activation of digestive 
enzymes leads to autodigestive injury and therefore is a key event in the development of 
chronic or acute pancreatitis.20, 21 Under physiological conditions, trypsinogen is 
synthesized by the acinar cells as inactive precursor, transferred to the duodenum via the 
pancreatic ducts, and then activated by enteropeptidases in the small intestine.22 PAR-2 is a 
cell surface receptor for trypsin-like proteases. Several studies indicated that trypsin 
stimulates enzyme secretion from acinar cells via PAR-2.23, 24 In contrast, the effect of 
trypsin on PDECs is contradictory, higly depends on the species and the localization of 
PAR-2. Trypsin stimulates HCO3- secretion in Capan-1, human pancreatic ductal cell 
line,25 whereas inhibit HCO3- efflux from bovine PDECs.26 Moreover, activation of 
basolateral PAR-2 stimulates,25, 27 whereas apical PAR-2 inhibits26 ductal HCO3- secretion. 
In contrast, no data is available regarding the effect of trypsin on CFTR, however CFTR 
Cl- channel plays an essential role in ductal HCO3- secretion. Therefore, in this study our 
aim was to characterize the effect of trypsin and the PAR-2-AP on CFTR activity.  
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2. MATERIALS AND METHODS 
2.1. Ethics 
 
All experiments were conducted in compliance with the Guide for the Care and 
Use of Laboratory Animals (U.S.A. NIH publication No85-23, revised 1985). Animal 
experiments were approved by the Rregional Ethical Board at the University of Szeged, 
Hungary. 
2.2. Capan-1 cell culture  
 
Capan-1 cells were grown in Roswell Park Memorial Institute (RPMI)-1640 
Medium supplemented with 15 % fetal bovine serum, 1 % penicillin–streptomycin.Cells 
from passage numbers 20–60 were used in this study. For electrophysiological 
measurements, 5×105 cells were plated onto 24 mm diameter glass coverslips and used for 
experiments after 3 to 4 days of culture (~60–80 % confluency). 
2.3. Isolation of pancreatic ductal cells  
 
Four- to eight-week-old guinea pigs were humanly killed by cervical dislocation 
and then the pancreas was removed. Intra/interlobular ducts were isolated by enzymatic 
digestion and microdissection from the pancreas and then cultured overnight as previously 
described.28 To obtain single pancreatic ductal cells, cultured ducts were incubated for 50 
min at 37°C in 50 U/ml elastase dissolved in storage solution (Dulbecco's modified Eagle's 
medium containing 3 % (w/v) bovine serum albumin (pH 7.4 with NaOH)). The ducts 
were then washed in a Ca2+/ Mg2+ -free Kreb's–Ringer HEPES buffer (pH 7.4) for 10 min 
further in order to stop elastase activity. After the incubation, ducts were teased apart using 
stainless steel needles. 
In the patch clamp experiments, one drop of cell suspension was placed within a 
transparent recording chamber, and single ductal cells were allowed to settle and attach to 
the bottom of the chamber for at least 30 min before perfusion was initiated. In the 
microfluorometric measurements, one drop of cell suspension was transferred to a poly-l-
lysine-coated cover slip (24 mm) forming the base of a perfusion chamber. Cells were then 
washed continuously with solutions at a rate of 1.5 or 5–6ml/min in the patch-clamp and 
microfluorometric measurements, respectively. Individual ductal cells were used within 3–
4 h after the isolation.  
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2.4. Whole cell current recording  
 
Patch-clamp micropipettes were fabricated from borosilicate glass capillaries 
(Clark, Reading, UK) using a P-97 Flaming/Brown micropipette puller (Sutter Co.Novato, 
CA, USA) and had resistances between 2.5 and 4 MΩ. Whole cell currents were recorded 
with Axopatch-1D patch clamp amplifier (Molecular Devices-Axon Instruments, Union 
City, CA, USA) at 37 °C.  
The standard extracellular solution contained (in mM) 145 NaCl, 4.5 KCl, 2 CaCl2, 
1 MgCl2, 10 HEPES and 5 glucose (pH 7.4 with NaOH). The osmolarity of the external 
solution was 300 mOsm/l. The standard pipette solution contained (in mM) 120 CsCl, 2 
MgCl2, 10 HEPES, 5 ethylene glycol-bis(b- aminoethyl ether)-N,N,N8,N8-tetraacetic acid 
(EGTA) and 1 Na2ATP (pH 7.2 with CsCl). The osmolarity of the pipette solution was 240 
mOsm/l. In some experiments, the ATP concentration was increased to 2 or 5 mM.  
After establishing a high (1–10 GOhm) resistance seal by gentle suction, the cell 
membrane was disrupted by further suction or by applying a 1.5 V electrical pulse for 1–
5ms. The series resistance was tipically 4-8 MOhm before compensation (50-80 %, 
depending on the voltage protocol). Membrane currents were digitized using a 333-kHz 
analog-to-digital converter (Digidata 1200, Molecular Devices-Axon Instruments, Union 
City, CA, USA) after low-pass filtering at 1 kHz under software control (PCLAMP 6.0, 
Molecular Devices-Axon Instruments, Union City, CA, USA). To obtain current/voltage 
(I/V) relationships, the membrane potential (Vm) was held at 0 mV and then clamped to 
±100 mV in 20 mV increments for 500 ms, with an 800 ms interval between each pulse. 
Currents were measured over a 4 ms period starting 495 ms into the voltage pulse. Mean 
current amplitudes were calculated at  ± 60 mVand normalised to cell capacitance (pF). 
2.5. Measurement of intracellular ATP 
 
Changes in intracellular ATP (ATPi) were estimated using the Mg2+-sensitive 
fluorescent dye, Magnesium Green-AM (MgGreen-AM). Most of the Mg2+ ions in the 
cells are bound to ATP. Since ATP has a higher affinity for Mg2+ than ADP, upon ATP 
hydrolysis the concentration of cytosolic free Mg2+ increases.29 Upon binding Mg2+, 
MgGreen exhibits an increase in fluorescence emission intensity which allows the indirect 
measurement of ATPi. Cells were incubated with 5 µM MgGreen-AM in the presence of 
0.05 % pluronic F-127 in standard HEPES solution (in mM: 130 NaCl, 5 KCl, 1 CaCl2, 1 
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MgCl2, 10 D-glucose and 10 Na-HEPES; pH was set to 7.4 with HCl) for 30 min at room 
temperature.  
Five to ten cells (region of interest, ROIs) were then excited with light at a 
wavelength of 490 nm, with emitted light monitored at 535 nm. The fluorescence 
emissions were captured by a CCD camera and digitized by an Xcellence imaging system 
(Olympus, Budapest, Hungary). One ATPi measurement was obtained per second. 
Fluorescence signals were normalised to initial fluorescence intensity (F/F0) and expressed 
as relative fluorescence. 
2.6. Chemicals 
 
Chromatographically pure collagenase was purchased from Worthington 
(Lakewood, NJ, USA). Mg-Green was from Invitrogen (Eugene, OR, USA). Forskolin was 
obtained from Tocris (Bristol, UK) and made up as a 50 mM stock solution in dimethyl 
sulphoxide (DMSO). Palmitoleic acid ethyl ester (POAEE) was purchased from Cayman 
Chemical (Estonia, Tallinn). PAR-2 antagonist (PAR-2-ANT, H-Phe-Ser-Leu-Leu-Arg-
Try-NH2) and PAR-2 activating peptide (PAR-2-AP, H-Ser-Leu-Ile-Gly-Arg-Leu-amin 
trifluoroacetate salt) was from Peptides International (Louisville, Kentucky, USA). All 
other chemicals were purchased from Sigma-Aldrich (Budapest, Hungary) and were of the 
highest grade available. Palmitoleic acid (POA) and POAEE were made up as a 10 mM 
stock solution in DMSO, and on the day of the experiment, an appropriate quantity of the 
stock POA was dissolved in Krebs or HEPES. Emulsification of POA was achieved by 
sonication.  
2.7. Statistics  
 
Data are expressed as means ± SEM. Significant difference between groups was 
determined by Student's t -test or by analysis of variance. Probability values ≤ 0.05 were 
accepted as significantly different.  
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3. RESULTS 
3.1. Measurement of CFTR conductance in guinea pig PDECs 
 
Our experimental conditions were designed to selectively study CFTR channel 
activity in PDECs as described previously.30 In order to block potassium conductances, we 
used a CsCl-rich pipette solution, whereas Ca2+-activated Cl- currents were inhibited by 
using 5 mM intracellular EGTA to lower Ca2+ levels to ~10 nM. After establishing a whole 
cell recording, a small resting current was observed (23±2.5 pA/pF at ± 60 mV; Fig. 3A—
i), with a mean reversal potential of −5.6 mV, which is very close to the Cl- equilibrium 
potential (~ −5.7 mV; Fig. 3B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3. CFTR Cl- currents in single native guinea pig PDECs. Whole cell currents were obtained by applying 500 ms 
duration voltage-clamp steps ranging between −100 and +100 mV in 20 mV steps from a holding potential of 0 mV in a 
normal bath solution with a CsCl-rich pipette solution. (A) Representative whole cell currents recorded before 
stimulation (i), during stimulation with forskolin (5 µM) (ii) and after washout of forskolin from the bath (iii). (B) 
Current/voltage (I/V) relationships were obtained by measuring currents over a 4 ms period starting 495 ms into the 
voltage pulse. The currents were measured under basal conditions (diamonds), during exposure to forskolin (squares) and 
after washout of forskolin from the bath (triangles). (C, D) Summary of current densities (measured at + 60 mV) in basal 
(C) and in forskolin-stimulated (D) cells in the presence of CFTR inhibitor, CFTRinh-172 (10 µM). The current densities 
have been normalised to the cell input capacitance. Data are presented as means ± SEM. *p <0.05 vs forskolin, n =7–10 
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Administration of 5 µM forskolin (cAMP agonist) to the bathing solution increased whole 
cell currents by approximately tenfold in 70 % of cells (Fig. 3A—ii). The forskolin-
activated currents were voltage-independent with a linear I/V relationship (Fig. 3B) and 
decreased after removal of forskolin from the external solution (Fig. 3A—ii). To confirm 
that the basal and stimulated currents were both mediated by CFTR, we tested CFTRinh-
172, a potent inhibitor of the channel. Administration of 10 µM CFTRinh-172 reversibly 
and significantly blocked the basal currents by 58.2 ± 5.7 % (at + 60 mV; Fig. 3C) and 
forskolin-stimulated currents by 66.6 ± 6.4 % (at + 60 mV; Fig. 3D), providing further 
evidence that under our experimental conditions the whole cell currents were due to CFTR. 
 
3.2. EtOH increases the basal but inhibits the forskolin-stimulated 
CFTR currents 
 
We examined the effect of 1–100 mM EtOH on both basal and forskolin-stimulated 
whole cell currents. Exposing duct cells to 1 mM EtOH had no significant effect on basal 
or forskolin-activated CFTR currents, even after 15 min of administration (Fig. 4C, F). 
Increasing the EtOH concentration to 10 mM significantly increased the basal current by 
32.6 ± 10.2 % after 15 min of administration (at + 60 mV; Fig. 4A–C), whereas 100 mM 
EtOH induced a robust increase within 5 min (110.1 ± 7.2 % at + 60 mV; Fig. 4A–C). In 
contrast, both 10 and 100 mM EtOH blocked the forskolin-stimulated whole cell currents 
(31.4 ± 9.6 and 66.5 ± 5.4 %, respectively, after 15 mins at + 60 mV; Fig. 4D-F). Both the 
stimulatory and inhibitory effects of EtOH were reversible on washout. In addition, block 
by EtOH was not voltage dependent (Fig. 4B, E). 
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Fig. 4. Effect of EtOH on basal and forskolin-stimulated CFTR currents in single native guinea pig PDECs. Whole 
cell currents were recorded as described in Fig. 3. Basal conditions (A–C): (A) representative whole cell currents 
recorded under basal conditions (i), after 15 min from administration of EtOH (100 mM) (ii) and after washout of EtOH 
from the bath (iii). (B) Current–voltage (I/V) relationships were obtained as described in Fig. 3. The currents were 
measured under basal conditions (diamonds), during 15 min of exposure to 100mM EtOH (squares) and after washout of 
EtOH from the bath (triangles). (C) Summary of current densities (measured at  + 60 mV) in control, in the presence of 
EtOH (1, 10 and 100 mM) and after washout of EtOH from the bath. The current densities have been normalised to the 
cell input capacitance. Data are presented as means ± SEM. *p <0.05 vs control, n =10–13. Forskolin-stimulated cells 
(D–F): (D) representative whole cell currents recorded before stimulation (i), during stimulation with forskolin (5 µM) 
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(ii), in the presence of 100 mM EtOH (15 min) (iii), after removal of EtOH from the bath (iv) and after washout of 
forskolin from the bath (v). (E) Current/voltage (I/V) relationships were obtained as described in Fig. 3. The currents 
were measured under basal conditions (diamonds), during stimulation with forskolin in the absence (squares) and 
presence (triangles) of EtOH (100 mM) and after washout of forskolin from the bath (circles). (F) Summary of current 
densities (measured at + 60 mV) in control, in forskolin-stimulated cells, in the presence of EtOH (1, 10 and 100 mM, 
respectively) and after washout of forskolin and EtOH from the bath. The current densities have been normalised to the 
cell input capacitance. Data are presented as means ± SEM. *p <0.05 vs forskolin, n =10–13.  
 
The rate of the mannitol-induced increase in whole cell currents was similar to the 
rate of EtOHinduced increase, indicating that the stimulatory effect of a high concentration 
of EtOH on the basal current is likely to be via an osmotic effect. In contrast to EtOH, 
mannitol did not decrease but significantly increased the forskolinstimulated currents by 
49.7±10.2 % (after 15 mins at + 60 mV; Fig. 5B), suggesting that the inhibitory effect of 
EtOH is independent of its osmotic effect. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Effect of mannitol on basal and 
forskolin-stimulated CFTR currents 
in single native guinea pig PDECs. 
Summary of current densities (measured 
at + 60 mV) in basal (A) and forskolin-
stimulated cells (B) in the presence of 
177 mM mannitol. The current densities 
have been normalised to the cell input 
capacitance. Data are presented as means 
± SEM. *p <0.05 vs control, **p <0.05 
vs forskolin, n =6–7 
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3.3. Effects of EtOH metabolites on basal and forskolin-stimulated 
CFTR currents 
 
Ac is the end product of oxidative EtOH degradation, whereas the non-oxidative 
degradation of EtOH produces FAEEs. Using the same conditions as the EtOH 
experiments, neither 1 nor 5 mM Ac had any effect on basal or forskolin-stimulated CFTR 
currents (data not shown, n =5).  
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Fig. 6. Effect of POAEE on basal and forskolin-stimulated CFTR currents in single native guinea pig PDECs. 
Whole cell currents were recorded as described in Fig. 3. Basal conditions (A–C): (A) representative whole cell currents 
recorded under basal conditions (i), after 5 min of administration of POAEE (200 µM) (ii) after 10 min of administration 
of POAEE (200 µM) (iii) after 15 min of administration of POAEE (200 µM) (iv) and after washout of POAEE from the 
bath (v). (B) Current–voltage (I/V) relationships were obtained as described in Fig. 3. The currents were measured under 
basal conditions (diamonds), during 15 min of exposure to 200 µM POAEE (squares) and after washout of POAEE from 
the bath (triangles). (C) Summary of current densities (measured at + 60 mV) in control, in the presence of POAEE (10, 
100 and 200 µM, respectively) and after washout of POAEE from the bath. The current densities have been normalised to 
the cell input capacitance. Data are presented as means ± SEM. *p <0.05 vs control, n =10–13.  Forskolin-stimulated 
cells (D–F): (D) representative whole cell currents recorded before stimulation (i), during stimulation with forskolin (5 
µM) (ii), in the presence of 200 µM POAEE (15 min) (iii), after removal of POAEE from the bath (iv) and after washout 
of forskolin from the bath (v). (E) Current/voltage (I/V) relationships were obtained as described in Fig. 3. The currents 
were measured under basal conditions (diamonds), during stimulation with forskolin in the absence (squares) and 
presence (triangles) of POAEE (200 µM) and after washout of forskolin from the bath (circles). (F) Summary of current 
densities (measured at + 60 mV) in control, in forskolin-stimulated cells, in the presence of POAEE (10, 100 and 200 
µM, respectively) and after washout of forskolin and POAEE from the bath. The current densities have been normalised 
to the cell input capacitance. Data are presented as means ± SEM. *p <0.05 vs forskolin, n =8-10.  
 
POAEE, an unsaturated non-oxidative metabolite of EtOH, also had no effect on 
the basal currents over the concentration range of 10–200 µM (Fig. 6A–C). However, in 
marked contrast, 200 µM POAEE was able to block the forskolin-stimulated CFTR 
currents by 56.1± 12.3 % after 15 min of exposure (at + 60 mV; Fig. 6D–F). 
The unsaturated FA, POA, at low concentrations (10 µM) did not affect the basal or 
forskolin-stimulated CFTR currents (Fig. 7C, F). However, at higher concentrations (100 
and 200 µM), POA induced a dose-dependent and significant decrease in both the basal 
currents (63.6±5.2 and 68.4±5.5 % at+60 mV, respectively; Fig. 7A–C) and forskolin-
stimulated CFTR currents (72.1±4.2 and 70.1±6.7 % at + 60 mV, respectively; Fig. 7D–F). 
The inhibitory effect of POAEE and POA (100 and 200 µM) reached a maximum after 5 
and 15 min of administration, respectively, and were always reversible on washout. 
The formation of FAEEs from EtOH and FAs is catalysed by the enzyme FAEE 
synthase,17 whereas FAEE hydrolase is responsible for the reverse reaction. The highest 
activities of FAEE synthases/hydrolases are found in the liver and pancreas.31 A number of 
FAEE synthases have been identified, and among them pancreatic cholesterol ester 
synthase and pancreatic carboxylester synthase have been shown to possess some FAEE-
synthesizing activity in the pancreas.32, 33 Although several studies have demonstrated that 
FAEEs are involved in organ injury, we wanted to test whether the inhibitory effect of 
POAEE depended on its hydrolysis. For this, we treated the cells with 200 µM bis-(4-
nitrophenyl) phosphate (BNPP), an inhibitor of FAEE hydrolase.34 Fifteen minutes of 
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treatment with this agent did not change the basal or forskolin-stimulated whole cell 
currents, indicating that BNPP alone has no effect on CFTR activity. In contrast, BNPP 
treatment almost completely abolished the inhibitory effect of POAEE on forskolin-
stimulated currents (187.3±12.9 to 141.6±4.7 pA/pF; 15 min of administration of POAEE 
at + 60 mV), strongly suggesting that formation of POA is a crucial step in the inhibitory 
effect of POAEE/EtOH. 
 
 
 
 
Fig. 7. Effect of POA on basal and forskolin-stimulated CFTR currents in single native guinea pig PDECs. Whole 
cell currents were recorded as described in Fig. 3. Basal conditions (A–C): (A) Representative whole cell currents 
recorded under basal conditions (i), after 5 min of administration of POA (200 µM) (ii) after 10 min of administration of 
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POA (200 µM) (iii) after 15 min of administration of POA (200 µM) (iv) and after washout of POA from the bath (v). (B) 
Current–voltage (I/V) relationships were obtained as described in Fig. 3. The currents were measured under basal 
conditions (diamonds), during 15 min of exposure to 200 µM POA (squares) and after washout of POA from the bath 
(triangles). (C) Summary of current densities (measured at + 60 mV) in control, in the presence of POA (10, 100 and 200 
µM, respectively) and after washout of POA from the bath. The current densities have been normalised to the cell input 
capacitance. Data are presented as means ± SEM. *p <0.05 vs control, n =10–13. Forskolin-stimulated cells (D–F): (D) 
representative whole cell currents recorded before stimulation (i), during stimulation with forskolin (5 µM) (ii), in the 
presence of 200 µM POA (15 min) (iii), after removal of POA from the bath (iv) and after washout of forskolin from the 
bath (v). (E) Current/voltage (I/V) relationships were obtained as described in Fig. 3. The currents were measured under 
basal conditions (diamonds), during stimulation with forskolin in the absence (squares) and presence (triangles) of POA 
(200 µM) and after washout of forskolin from the bath (circles). (F) Summary of current densities (measured at + 60 mV) 
in control, in forskolin-stimulated cells, in the presence of POA (10, 100 and 200 µM, respectively) and after washout of 
forskolin and POA from the bath. The current densities have been normalised to the cell input capacitance. Data are 
presented as means ± SEM. *p <0.05 vs forskolin, n =8-10.  
 
3.4. EtOH, POAEE and POA cause ATPi depletion in PDECs, 
which is linked to CFTR inhibition 
 
We next investigated the intracellular mechanism by which EtOH, and its non-
oxidative metabolites, exerts its inhibitory effect on CFTR. Previous studies have shown 
that EtOH and monounsaturated FAs, such as POA, promote opening of the permeability 
transition pore, which leads to mitochondrial depolarization and finally cell death.35, 36 
Since no data are available regarding the effect of FAs on mitochondrial function in 
PDECS, we investigated the effect of EtOH, and its non-oxidative metabolites, on 
mitochondrial injury using microfluorometric technique. PDECs were loaded with the 
Mg2+-sensitive fluorescent dye, MgGreen-AM, which allows an indirect measurement of 
ATPi.29 Administration of 100 mM EtOH caused a small ATPi depletion in 75% of cells 
(Fig. 8A–C), whereas POA or POAEE (200 µM) induced a marked increase in MgGreen 
fluorescence intensity, which reached a plateau about 5 min after the administration of the 
metabolites (Fig. 8A–C). We have previously shown that inhibitors of both oxidative and 
glycolytic metabolism, carbonyl cyanide m-chlorophenyl hydrazone (CCCP; 100 µM) and 
2-deoxyglucose/iodoacetamide (DOG/IAA, 10 mM), respectively, caused a marked and 
irreversible depletion of ATPi in guinea pig pancreatic ductal cells.37 
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Fig. 8. EtOH, POA and POAEE cause ATPi depletion in single native guinea pig PDECs and reduce the activity of 
CFTR. (A) Representative curves of the MgGreen fluorescence experiments. A decrease in [ATP]i is shown by an 
increase in fluorescence intensity. High concentration of EtOH (100 mM), POAEE (200 µM) and POA (200 µM) induced 
significant ATPi depletion after 15 min of administration. (B) Summary data for the maximal fluorescence intensity 
changes. Data are shown as means ± SEM from 25–35 ROIs in three to five experiments for all groups. *p<0.05 vs 
forskolin, **p <0.05 vs control. (C) Light (1) and fluorescent images (2 and 3) of isolated pancreatic ductal cells showing 
the effects of 100 mM EtOH, 200 µM POAEE or 200 µM POA on [ATP]i. Pictures were taken before (1 and 2) and after 
(3) exposure of the cells to EtOH, POAEE or POA. (D) Summary of current densities (measured at + 60 mV) for basal 
and forskolin-stimulated (E) cells in the presence of a mixture of 100 µM CCCP and 10 mM DOG/IAA. The current 
densities have been normalised to the cell input capacitance. Data are presented as means ± SEM. *p<0.05 vs control and 
forskolin, n =3. N.D. not detected 
 
In order to decide whether the inhibitory effect of EtOH, POA and POAEE on 
CFTR was linked to the depletion of ATPi, we tested the effect of CCCP/DOG/IAA 
administration on CFTR currents and found that this combination of inhibitors blocked 
both the basal (Fig. 8D) and forskolin-stimulated currents (Fig. 8E) in a similar manner to 
EtOH, POA and POAEE. After the removal of CCCP/DOG/IAA from the external 
solution, the currents did not return to the initial levels, indicating that CCCP/DOG/IAA 
irreversibly inhibit CFTR, probably due to the maintained depletion of ATPi. 
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3.5. Intracellular ATP supplementation reverses the inhibitory 
effect of EtOH, POAEE and POA on CFTR activity in PDECs 
 
To investigate further the apparent relationship between the inhibitory effect of 
EtOH, POA and POAEE on CFTR channel activity and depletion of ATPi, we tested 
whether raising ATPi levels in PDECs would result in a better tolerance to these agents. 
Increasing the ATPi concentration in the pipette solution from 1 mM to either 2 or 5 mM 
did not produce a detectable alteration in the size, or properties, of the basal or forskolin-
stimulated CFTR currents (data not shown), suggesting that ATP was not limiting for 
CFTR activity under all conditions. Next, we studied the effect of 100 mM EtOH, 200 µM 
POAEE or 200 µM POA on CFTR currents in the presence of 2 mM ATP in the pipette. 
Supplementation of the pipette solution with 2 mM ATP did not influence the effects of 
EtOH or its non-oxidative metabolites on CFTR currents (data not shown). In contrast, 
increasing the ATP concentration to 5 mM completely prevented the inhibitory effect of 
EtOH (Fig. 9A) and POAEE (Fig. 9B) on forskolin-stimulated currents, as well as the 
effect of POA on the basal (Fig. 9C) and forskolin-stimulated CFTR currents (Fig. 9D). 
These results indicate that inhibition of CFTR by EtOH//POAEE/POA is likely due to a 
reduction of ATPi and/or to a change in ATPi interaction with CFTR. 
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Fig. 9. Intracellular ATP supplementation reversed the inhibitory effect of EtOH, POAEE and POA on CFTR 
activity in guinea pig PDECs. Summary of current densities (measured at + 60 mV) in forskolin-stimulated cells in the 
presence of 100 mM EtOH (A), 200 µM POAEE (B) and 200 µM POA (C) and under basal conditions in the presence of 
200 µM POA (D). Current densities have been normalised to the cell input capacitance. Data are presented as means ± 
SEM. *p <0.05 vs. forskolin, **p <0.05 vs. control, n =5–10. 
 
3.6. Low concentration of EtOH stimulates whereas high 
concentration os EtOH and fatty acids inhibit forskolin-stimulated 
CFTR current in human PDECs 
 
To extend these studies to human PDECs, we used a human ductal adenocarcinoma 
cell line, Capan-1, which has been shown to express CFTR.38 We used the same 
concentrations of EtOH, POA and POAEE than on guinea pig PDEC and we found similar 
results. Consequently, patch-clamp experiments revealed that 10 mM EtOH increased, 
whereas, 100 mM EtOH or 200 µM POA significantly decreased forskolin-stimulated 
CFTR Cl- currents (Fig.10). In both cases, inhibition was voltage-independent and 
irreversible (unpublished data). 
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Fig. 10. Effect of EtOH and its metabolites on forskolin-stimulated CFTR currents in CAPAN-1 cell line. 
(A) Representative fast whole cell CFTR Cl- current recordings from Capan-1 cells. (i) Unstimulated currents, currents 
after 10 min stimulation with 10µM forskolin (Forsk), and (iii) stimulated currents following 10 min exposure to 10 or 
100mM ethanol and 200µM POA (iv) I/V relationships. Diamonds represent unstimulated currents, squares represent 
forskolin-stimulated currents, and triangles represent forskolin stimulated currents in the presence of the tested agents. 
(B) Summary of the current density (pA/pF) data measured at Erev ±60 mV. The current densities have been normalised 
to the cell input capacitance. Exposing the Capan-1 cells to 10mM ethanol stimulated, 100mM ethanol or 200µM POA 
blocked the forskolin-stimulated CFTR Cl- currents. n: 5-6 for all groups. a: p<0.05 vs basal current; b: p<0.05 vs 
forskolin-stimulated current. 
 
 
 
 
A 
 
B 
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3.7. ATPi supplementation in human PDECs 
 
Next we investigated the effect of ATPi supplementation on the inhibitory effect of 
POA. Similar to guinea pig PDECs, 200 µM POA decreased the forskolin-stimulated 
CFTR currents by 69.7±3.2 % (from 86.7±7.1 to 27.7±6.8 pA/pF at + 60 mV; Fig. 11A, 
B). Administration of 2 mM intracellular ATP did not affect the inhibitory effect of POA; 
however, in the presence of 5 mM intracellular ATP, this inhibition was significantly 
reduced to 36.1±3.2 % (Fig. 11A, B). 
 
 
 
 
 
 
Fig. 11. Effect of intracellular ATP supplementation in Capan-1 cells exposed to POA. (A) Representative whole 
cell currents recorded under basal conditions (i), after administration of forskolin (5 µM) (ii), after 15 min of 
administration of POA (200 µM) (iii ), in the presence of 1.0 mM ATP (top set of traces) or 5.0 mM ATP (bottom set of 
current traces). Current–voltage (I/V) relationships were obtained as described in Fig. 2. The currents were measured 
under basal conditions (diamonds), during stimulation with forskolin (squares ) and in the presence of 200 µM POA 
(triangles). (B) Summary of current densities measured at + 60 mV. Current densities have been normalised to the cell 
input capacitance. Data are presented as means ± SEM. a p<0.05 vs forskolin, b p< 0.05 vs 1 mM ATP (200 µM POA), n 
=8–12 
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3.8. Trypsin and PAR-2-AP inhibit CFTR 
 
Exposure of PDECs to 10 µM trypsin did not affect the basal CFTR currents; 
however, administration of either 10 µM PAR-2-AP (Fig. 12A (iii)) or 10 µM trypsin (Fig. 
12B (iii)) inhibited forskolin-stimulated CFTR currents by 51.7% ± 10.5% and 57.4% ± 
4.0%, respectively. In both cases, the inhibition was voltage independent and irreversible. 
Pretreatment with either soybean trypsin inhibitor (SBTI; 10 µM; Fig. 10C (iii)) or PAR-2 
antogonist (PAR-2-ANT; 10 µM; Fig. 12D (iii)) completely prevented the inhibitory effect 
of trypsin on the forskolin-stimulated CFTR currents. Fig. 12E is a summary of these data, 
which suggest that trypsin inhibits CFTR currents by activation of PAR-2. 
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Figure 12. Effects of trypsin and PAR-2-AP on CFTR Cl- currents of guinea pig pancreatic duct cells. 
Representative fast whole cell current recordings from PDECs. (A–D) (i) Unstimulated currents, (ii) currents after 
stimulation with 5 µM forskolin, and (iii) currents following 3 minute exposure to (A) 10 µM PAR-2-AP, (B) 10 µM 
trypsin, (C) 10 µM trypsin/5 µM SBTI, and (D) 10 µM trypsin/10 µM PAR-2-ANT. (iv) I/V relationships. The currents 
were measured under basal condition (diamonds), during stimulation with forskolin (squares), and triangles represent 
forskolin-stimulated currents in the presence of the tested agents (see previous text). (E) Summary of the current density 
(pA/pF) data obtained from A–D measured at Erev ± 60 mV. Exposing PDECs to either PAR-2-AP or trypsin blocked the 
forskolin-stimulated CFTR Cl- currents, while administration of SBTI or PAR-2-ANT prevented the inhibitory effect of 
trypsin. n = 6 for all groups. *: p<0.05 vs the unstimulated cells, **: p<0.05 vs forskolin. FORSK, forskolin; TRYP, 
trypsin, PAR-AP, PAR-2 activating peptide; PAR2-ANT, PAR-2 antagonist; SBTI: soybean trypsin inhibitor. 
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4. DISCUSSION 
 
AP is a sudden inflammation of the pancreas. The severity of the disease can vary 
from a mild to a fulminant disorder with high morbidity and mortality.38 Most cases of AP 
are closely linked to heavy alcohol consumption,38 therefore a number of studies have 
investigated the effects of EtOH on the pancreas.34, 39-45 Most of these studies are focused 
on the effect of EtOH on acinar and stellate cells, however much less research have been 
done on ductal cells. 
One of the major functional cell types of the exocrine pancreas is the ductal cell. In 
these cells, the CFTR Cl- channel operate paralell with the Cl-/HCO3- exchangers on the 
apical membrane to provide a daily supply of~2.5 L of a HCO3- rich fluid secretion, which 
is essential for normal exocrine gland function.2, 46 Mutations in the cftr gene are often 
associated with pancreatitis. Several loss of function CFTR mutations have been shown to 
impair ductal fluid and HCO3- secretion and lead to the development of acute47, 48 or 
chronic pancreatitis49-51 or are responsible for certain cases of idiopathic pancreatitis.52-54 In 
addition, the frequency of CFTR mutations in patients with alcoholic pancreatitis is twice 
as high compared to the general population.13 In contrast, the functional insufficiency of 
normal CFTR and its role in alcoholic pancreatitis is less characterized. In the present 
study, we show that EtOH, its non-oxidative metabolite POAEE and the FA, POA strongly 
inhibit CFTR Cl-  channel activity in guinea pig PDECs when measured using the whole 
cell configuration of the patch clamp technique.We demonstrated that 1 mM EtOH (blood 
alcohol level reached during moderate social drinking) had no effect on basal or forskolin-
stimulated CFTR channel activity. However, at higher concentrations such as 10 or 100 
mM (which is equivalent to a lethal blood alcohol level in humans55), EtOH increased the 
basal and decreased the forskolin-stimulated CFTR currents. The present observation that 
low concentrations of EtOH (1 mM) had no effect whereas high concentrations (10 and 
100 mM) inhibit secretagogue-stimulated CFTR activity is in agreement with previous 
observations that alcohol exerts dose-dependent effects on the pancreas.56 Using an 
equivalent concentration of mannitol, we show that the stimulatory effect of EtOH is likely 
to be due to an osmotic effect, whereas the inhibitory effect is independent of any the 
change in osmolarity. 
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 Several experimental studies have shown a key role of EtOH metabolites in the 
development of pancreatitis.57 Therefore, in this study we also investigated the effect of the 
oxidative and non-oxidative EtOH metabolites on the acitivity of CFTR. Previous studies 
have demonstrated that Ac, an oxidative metabolite of EtOH, strongly inhibits NF-κB 
binding activity42 and cholecystokinin-induced secretion58 in isolated rat pancreatic acinar 
cells and, at higher concentrations, causes morphological alterations in the rat pancreas.59 
In contrast, our study showed that Ac had no effect on CFTR activity or on ATPi; 
furthermore, it did not cause any morphological changes in ductal cells even at high 
concentrations (5 mM), indicating that PDECs are probably not involved in the toxic effect 
of Ac in the pancreas. On the contrary to oxidative metabolism, the pancreas has a very 
high capacity to metabolise EtOH through a non-oxidative pathway,60 and consequently 
the concentration of these metabolites is higher in the pancreas than in any other organ.16 
Previous studies have shown that at relatively low concentrations FAEEs are able to induce 
pancreatic injury,61 whereas at higher concentrations they cause toxic calcium signalling in 
acinar cells and disrupt the mitochondrial oxidative chain, which leads to ATPi depletion 
and finally cell death.34, 44 In addition, the pivotal role of FAEEs in the pathophysiology of 
alcoholic pancreatitis is also supposed by the fact that high concentrations of FAEEs have 
been detected in the pancreas at autopsy after acute alcohol intoxication and in chronic 
alcoholics.16 Our studies showed for the first time that the unsaturated FA, POA and its 
esterized form, POAEE reversibly and time-dependently inhibit CFTR activity in PDECs.  
In the next step we wanted to identify the intracellular mechanism by which EtOH, 
POA and POAEE exert their inhibitory effect on CFTR. The CFTR Cl-  channel is a 
member of ATP-binding cassette (ABC) transporter superfamily, which also binds and 
hydrolyses ATP in order to drive conformational rearrangements of its transmembrane 
domains.62-64 Thus, a supply of ATP is essential for CFTR function, and in the absence of 
ATP the activity of CFTR dramatically decreases.65, 66 Since FAs and FAEEs have 
previously been shown to cause ATP depletion in rat pancreatic acinar cells,34 we 
investigated if ATP depletion could underlie the effects of EtOH, POAEE and POA on 
CFTR activity in PDECs. Our results show that all three compounds decrease the level of 
ATPi in the ductal cells (Fig. 9). POA caused a significantly greater decrease in ATPi than 
POAEE. In addition, longer administration of POA did not cause a further increase in ATPi 
(as based on Mg-Green fluorescence intensity), indicating that 200 µM POA likely induced 
nearly complete ATPi depletion in PDECs. Consistent with this, inhibition of glycolytic 
and mitochondrial ATP production reduced CFTR currents to a similar degree to that 
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caused by EtOH, POA and POAEE, which strongly suggests that depletion of ATPi is a 
key step in the inhibitory effect of these agents on CFTR. Based on these results, we tested 
whether administration of ATPi back to the cell via the patch pipette is able to prevent the 
inhibitory effect of EtOH, POA and POAA on CFTR. Addition of 5 mM intracellular ATP 
almost completely abolished the inhibitory effect of these agents on CFTR activity (Fig. 8). 
Moreover similar results were found in Capan-1 cells, where supplementation of ATPi was 
also able to decrease the inhibitory effect of POA on CFTR.  
In the second part of this thesis we investigated the effect of trypsin on CFTR 
activity. It is generally believed that the earliest events in acute pancreatitis is the zymogen 
activation which is mediated by lysosomal hydrolases such as cathepsin B and produces 
active trypsin. Active trypsin than activates other zymogens resulting in cell injury.67 Since 
acinar cells synthesize, store and secrete the inactive proforms of digestive enzymes and 
this cell type accounts for 80.3% of the total pancreas volume, most of the research on the 
effect of trypsin have been done on acinar cells. In contrast, much less studies have been 
done on ductal cells. PAR-2 is a specific receptor of trypsin and it has been shown that 
activation of this receptor stimulates enzyme secretion from acinar cells.23, 24 In the ductal 
cells, activation of PAR-2 is able to modulate the rate of HCO3- secretion.25-27 These 
studies mainly focused on the Cl-/HCO3- exchangers whereas no data is available regarding 
the effect of trypsin on the CFTR Cl- channel. Therefore, our next challenge was to 
identify whether trypsin can reduce ductal bicarbonate secretion via PAR-2 dependent 
inhibition of the CFTR Cl- channel in guinea pig PDECs using the whole cell configuration 
of the patch clamp technique. We showed, that both trypsin and PAR-2-AP irreversibly 
decreased forskolin-stimulated CFTR currents in PDECs and this inhibitory effect could be 
completely prevented by SBTI or PAR-2-ANT.  
Taken together we showed for the first time that high concentrations of EtOH, 
POAEE, POA and physiological concentration of trypsin and PAR-2-AP all strongly 
inhibit epithelial CFTR channel activity. Since the CFTR Cl- channel plays an essential 
role in ductal electrolyte and fluid secretion, we hypothesise that functional inhibition of 
this channel may be involved in the pathogenesis of AP. In addition, we found that the 
inhibitory effect of EtOH, POAEE and POA is mediated through the depletion of ATPi. 
Since the deleterious effects of EtOH and its metabolites could be prevented by 
maintaining cytosolic ATP levels we speculate that restoration of the intracellular energetic 
pool by ATP supplementation may represent a novel therapeutic target in the treatment of 
the disease. 
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7. ANNEX 
 
A CISZTÁS FIBRÓZIS TRANSZMEMBRÁN KONDUKTANCIA REGULÁTOR CL- 
CSATORNA SZEREPE A PANKREATITISZ KIALAKULÁSÁBAN 
 
Tézis kivonat 
 
I. BEVEZETÉS 
 
A pankreász egyik leggyakrabban előforduló megbetegedése az akut pankreatitisz (AP). 
Az AP a hasnyálmirigy hirtelen fellépő gyulladása, amelynek kialakulásában az 
emésztőenzimek idő előtti aktiválódása játszik alapvető szerepet. Mivel a hasnyálmirigy 
állományának nagy részét az acinus sejtek teszik ki, illetve az AP során fellépő szöveti 
károsodás elsősorban az acinus sejteket érinti, az AP-el kapcsolatos vizsgálatok 
középpontjában az acinus sejtek tanulmányozása áll. Az 1980-as évektől fordult a figyelem a 
duktális epitél sejtek (PDEC) felé, amikor is egy sejtizolálási metodika segítségével lehetőség 
nyílt az intakt duktuszok vizsgálatára. A PDEC legfőbb élettani szerepe, hogy egy HCO3--ban 
gazdag, izotónikus folyadékot szekretál, amely kimossa a duktális fából az emésztőenzimeket, 
valamint megfelelő pH-t biztosít a duodénumban az enzimek működéséhez. Az utóbbi évek 
kutatásai igazolták, hogy a duktális sejtek bikarbonát szekréciójában történő változások fontos 
szerepet játszhatnak a betegség kialakulásában és lefolyásában, ezért a duktális sejtek 
funkcionális elváltozásainak felderítése alapvető fontosságú lehet az akut pankreatitisz 
patogenezisének pontos megértéséhez, illetve terápiájának fejlődéséhez.  
A humán pankreasz duktális epitél sejtek igen nagy, 140 mM koncentrációban képesek 
HCO3- szekrécióra, melyben számos transzporter, ioncsatorna játszik szerepet. Ezen ion 
csatornák közül kiemelkedő az apikális membránon található cisztás fibrózis transzmembrán 
konduktancia regulátor (CFTR) Cl- csatorna szerepe. A CFTR egy cAMP által szabályozott 
ioncsatorna, amely elsősorban a Cl- transzportjában vesz részt. Működése a Cl-/ HCO3- 
kicserélővel szoros összhangban történik, biztosítva ezáltal a normál duktális 
folyadékszekréciót, amely a pankreász integritásának megőrzéséhez elengedhetetlen. A CFTR 
alapvető szerepe, hogy Cl--ot transzportál a duktális lumenbe és ezáltal biztosítja a  Cl- forrást 
a Cl-/HCO3- kicserélő működéséhez. Az utóbbi évek kutatásai rámutattak arra, hogy stimulált 
szekréció során a csatorna permeabilitása megváltozik és a Cl- transzportja mellett a HCO3--ra 
is permeábilissá válik, azonban a mechanizmus nem teljesen tisztázott.  
Köztudott, hogy a pankreatitisz kialakulásában az egyik fő etiológiai tényező a túlzott 
alkoholfogyasztás, míg a betegség pathomechanizmusában az idő előtt aktiválódott tripszin 
játszik alapvető szerepet.  
Az etanol és a tripszin hatását a duktális sejtekben elsősorban a HCO3- szekrécióra 
vizsgálták. Yamamoto és mtsai. kimutatták, hogy kis dózisú etanol hatására fokozódik a 
duktális sejtek szekretin-indukálta HCO3- szekréciója, míg a nagy koncentrációban (100 mM) 
adott etanol esetén a duktális szekréció csökken. A tripszin esetében elég ellentmondásosak az 
eredmények. A tripszin hatása a HCO3- szekrécióra nagymértékben függ a fajtól és a proteáz-
aktiválta receptor -2 (PAR-2) lokalizációjától. Humán pankreász duktális sejtvonalban a 
tripszin fokozza, míg szarvasmarhából izolált PDEC-n gátolja a HCO3- szekréciót. Továbbá a 
bazolaterális oldalon kifejeződő PAR-2 fokozza, míg az apikális oldalon kifejeződő PAR-2 
gátolja a duktális HCO3- szekréciót. Arra vonatkozóan azonban, hogyan befolyásolja az etanol 
vagy a tripszin a duktális CFTR csatorna működését nem lelhető fel adat az irodalomban.  
 
II. CÉLKITŰZÉSEK 
 
Kísérleteink során célul tűztük ki (i) az etanol (EtOH) és bomlástermékeinek vizsgálatát a 
CFTR csatorna aktivitására tengerimalac PDEC-ben és humán pankreász sejtvonalon, 
valamint a (ii) tripszin hatásának vizsgálatát a CFTR Cl- csatorna aktivitására tengerimalac 
PDEC-ben. 
 
III. ANYAGOK ÉS MÓDSZEREK 
 
Intakt pankreász duktuszok izolálása 
Az intra/interlobuláris duktuszokat 150-250 gramm tömegű tengerimalacok 
hasnyálmirigyéből izoláltuk. A hasnyálmirigyet kollagenáz enzimmel 30 percig emésztettük 
37 °C-on, majd a duktuszokat sztereomikroszkóp alatt mikrodisszekciós technikával izoláltuk. 
Az izolált duktuszokat 37 C°-on 5% CO2-t tartalmazó környezetben inkubáltuk 24 órán 
keresztül. Ezt követően az egyedi sejteket a duktuszokból 50 perces elasztázos emésztés és 
mikrodisszekciós technika kombinációjával nyertük. 
CAPAN-1 sejt vonal 
A Capan-1 sejteket Roswell Park Memorial Institute (RPMI)-1640 Medium oldatban 
tenyésztettük kiegészítve 15 % magzati marha szérum, valamint 1 % penicillin–streptomycin 
kombinációjával. A mérések során 20–60 passzázst elért sejteket használtunk. Az 
elektrofiziológiai vizsgálatokhoz 5×105 sejtet szélesztettünk 24 mm átmérőjű üveg lemezekre. 
A kísérleteket 3-5 nap elteltével végeztük, amikor a sejtek transzepitéliális ellenállása (TER) 
szignifikáns mértékben megemelkedett és a konfluencia elérte a ~60–80 % - ot. 
Intracelluláris ATP (ATPi) mérés 
Az ATPi szint méréséhez Xcellence (Olympus, Hungary) képalkotó rendszert 
használtunk. A sejteket 5 µmol/L Magnesium-Green-AM festékkel 30 percig töltöttük 
szobahőmérsékleten. Tekintettel arra, hogy az ATP-nek az ADP-hez viszonyítva 10x erősebb 
a magnézium ionokat kötő képessége, a sejten belüli Mg2+ ionok nagy része Mg2+-ATP 
formátumban van jelen. Ennek következtében a Mg2+-Green által kibocsátott fluoreszcens jel 
arányos lesz az ADP/ATP hányadossal, ezáltal jól követhető az ATPi szint változása. Ha a 
fluoreszcens intenzitás emelkedik, akkor az ATPi szint csökken. A sejteket 476 nm-en 
világítottuk meg és a fluoreszcens intenzitást 535 nm-en gyűjtöttük.  
Teljes sejtes patch-clamp mérés 
A CFTR csatorna aktivitását patch-clamp technika teljes-sejt (whole-cell) 
konfigurációjával vizsgáltuk. A kísérleteket szobahőmérsékleten végeztük. Méréseinkhez 
Axopatch-1D erősítőt használtunk, feszültség-zár üzemmódban. Az ingerlő feszültség 
impulzusokat és az adatgyűjtést számítógép-vezérelt AxonDigidata 1200 A/D konverter és 
pCLAMP 6 szoftver segítségével végeztük. Méréseink során szükség esetén soros ellenállás 
kompenzációt alkalmaztunk( 50-80%), a soros ellenálláson eső feszültségből adódó hiba 
korrekciójának érdekében. A pipettákat boroszilikát (Clark) üvegkapillárisokból húztuk, majd 
hővel políroztuk a hegyüket, így a pipetták ellenállása 2.5-4 MOhm volt. Az oldatok cseréjét 
gravitáció által hajtott perfúziós rendszer segítségével valósítottuk meg, folyamatos elszívás 
mellett. A külső oldat összetétele mM-ban: 145 NaCl, 4.5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES 
and 5 glucose (pH 7.4 ). A pipetta oldat összetétele mM-ban: 120 CsCl, 2 MgCl2, 10 HEPES, 
5 ethyleneglycol-bis(b-aminoethylether)-N,N,N8,N8-tetraacetic acid (EGTA) and 1 Na2ATP 
(pH 7.2). A külső oldat ozmolaritása 300 mOsm/l volt, míg a pipetta oldaté 240 mOsm/l. A 
kísérleteink során az ATP koncentrációja 2-5 mM –ig növeltük. 
 
 
 
 IV. EREDMÉNYEK 
Az etanol valamint bomlástermékeinek dózis- és időfüggő hatásának vizsgálata a CFTR 
Cl- csatorna aktivitására 
1. Az EtOH (100 mM), a palmitoleinsav etil-észter (POAEE; 200 µM) valamint a 
zsírsav, palmitoleinsav (POA; 100 és 200 µM) reverzibilisen gátolja a forskolin-stimulálta 
CFTR csatornát a tengerimalac hasnyálmirigy duktális sejtekben, valamint humán pankreász 
sejtvonalon. 
2. A POAEE gátló hatása a zsírsav- etil-észter hidroláz gátló, BNPP segítségével 
kivédhető volt. 
3. Az EtOH, POAEE és POA hatására a sejten belüli ATP szint jelentősen lecsökkent. 
4. Az intracelluláris ATP pótlásával kivédhető volt az EtOH, POAEE valamint a POA 
CFTR csatornára gyakorolt gátló hatása. 
A tripszin hatásának vizsgálata a CFTR Cl- csatorna aktivitására  
5. A tripszin (10 µM) gátolja a CFTR csatorna aktivitását, mely gátló hatás a PAR-2 
receptoron keresztül valósul meg. 
 
V. KÖVETKEZTETÉSEK 
A CFTR Cl- csatorna a hasnyálmirigy duktális sejtek luminális membránján 
elhelyezkedő anion csatorna, amely alapvető szerepet játszik a normál, duktális 
folyadékszekréció fenntartásában és ez által a hasnyálmirigy integritásának megőrzésében. 
Munkánk során elsőként mutattuk ki, hogy az EtOH, nem-oxidatív bomlásterméke, a 
POAEE, a zsírsav, POA valamint a tripszin gátolja a CFTR Cl- csatorna aktivitását. 
Kísérleteink során kimutattuk, hogy a POAEE gátló hatásában a zsírsav keletkezése alapvető 
fontosságú. Továbbá azt találtuk, hogy az EtOH, POAEE és POA hatására markáns ATPi 
csökkenés következik be, mely alapvető szerepet játszik a CFTR csatornára kifejtett gátló 
hatásukban. Az ATPi visszaadásával mind az EtOH, POAEE és POA gátló hatása 
kivédhetővé vált. 
Eredményeink azt mutatják, hogy a pankreatitisz kialakulásában szerepet játszó 
faktorok, úgymint az EtOH vagy az idő előtti tripszin aktiválódás erőteljesen gátolják a CFTR 
Cl- csatorna működését, amely alapvető szerepet játszhat az AP pathomechanizmusában. 
Továbbá eredményeink azt sugallják, hogy a sejten belüli ATP szint emelése egy új, terápiás 
lehetőséget jelenthet a betegség kezelésében. 
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MOLECULAR AND CELLULAR MECHANISMS OF DISEASE
Ethanol and its non-oxidative metabolites profoundly inhibit
CFTR function in pancreatic epithelial cells which is prevented
by ATP supplementation
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Abstract Excessive alcohol consumption is a major cause of
acute pancreatitis, but the mechanism involved is not well
understood. Recent investigations suggest that pancreatic ductal
epithelial cells (PDECs) help defend the pancreas from noxious
agents such as alcohol. Because the cystic fibrosis transmem-
brane conductance regulator (CFTR) Cl− channel plays a major
role in PDEC physiology andmutated CFTR is often associated
with pancreatitis, we tested the hypothesis that ethanol affects
CFTR to impair ductal function. Electrophysiological studies
on native PDECs showed that ethanol (10 and 100 mM) in-
creased basal, but reversibly blocked, forskolin-stimulated
CFTR currents. The inhibitory effect of ethanol was mimicked
by its non-oxidative metabolites, palmitoleic acid ethyl ester
(POAEE) and palmitoleic acid (POA), but not by the oxidative
metabolite, acetaldehyde. Ethanol, POAEE and POAmarkedly
reduced intracellular ATP (ATPi) which was linked to CFTR
inhibition since the inhibitory effects were almost completely
abolished if ATPi depletion was prevented. We propose that
ethanol causes functional damage of CFTR through an ATPi-
dependent mechanism, which compromises ductal fluid secre-
tion and likely contributes to the pathogenesis of acute pancre-
atitis. We suggest that the maintenance of ATPi may represent a
therapeutic option in the treatment of the disease.
Keywords Acute pancreatitis . Ethanol .CFTR .Fatty acids .
ATP
Abbreviations
Ac Acetaldehyde
AP Acute pancreatitis
ATPi Intracellular ATP
BNPP bis-(4-Nitrophenyl) phosphate
CCCP Carbonyl cyanide m-chlorophenyl
hydrazone
CFTR Cystic fibrosis transmembrane
conductance regulator
DMSO Dimethyl sulphoxide
DOG 2-Deoxyglucose
IAA Iodoacetamide
EGTA Ethylene glycol tetraacetic acid
FA Fatty acid
FAEE Fatty acid ethyl ester
MgGreen-AM Magnesium Green-AM
PDECs Pancreatic ductal epithelial cells
POA Palmitoleic acid
POAEE Palmitoleic acid ethyl ester
Introduction
Acute pancreatitis (AP) is a potentially fatal disease charac-
terized by local complications (pancreatic necrosis, abscess
and pseudocyst) and/or systemic organ failure. The overall
mortality rate of AP is between 2.1 and 7.8 % worldwide [66].
This unacceptably high mortality rate is primarily due to the
lack of specific clinical treatments. It is well known that heavy
alcohol consumption is one of the leading causes of acute
pancreatitis [49, 68]. The cellular mechanism by which etha-
nol induces pancreatitis is not completely understood. Most of
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the research into the pathogenesis of alcoholic pancreatitis has
focused on the functional effects of ethanol on pancreatic
acinar and stellate cells. Studies on acinar cells have shown
that ethanol exerts its toxic effect by sensitizing acini to
cholecystokinin-induced zymogen [34] and NF-κB activation
[23] in vitro or to various forms of pancreatitis in vivo [52,
57]. In addition, Criddle et al. [15] have shown that at rela-
tively high concentrations, ethanol induces a small increase in
intracellular calcium concentration of mouse acini. Moreover,
they found that the end products of non-oxidative ethanol
degradation, fatty acid ethyl esters (FAEEs), were more toxic
to the cells than ethanol itself because these FAEEs led to
sustained intracellular calcium elevation and ATP depletion
in acinar cells [15, 16]. The toxic effects of FAEEs on pancre-
atic acini were also confirmed in vivo [79]. Ethanol infusion in
the presence of inhibitors of oxidative ethanol metabolism
worsened the ethanol-induced pancreatic injury in the rat
[79]. The effect of ethanol on pancreatic stellate cells has been
mainly characterized by Apte et al. [2, 4, 45]. They showed
that both ethanol and acetaldehyde (Ac) activate stellate cells
through the switching on of mitogen-activated protein kinases.
Activation of stellate cells then leads to pancreatic fibrosis, one
of the characteristic features of alcoholic pancreatitis [2, 4, 45].
In contrast to acinar and stellate cells, the effect of ethanol,
or its non-oxidative metabolites, on pancreatic ductal epithe-
lial cells (PDECs) is much less characterized. PDECs secrete a
bicarbonate-rich fluid which is crucially important in the
maintenance of normal pancreatic function [6]. This isotonic,
alkaline fluid neutralises protons secreted by acinar cells [27],
curtails premature trypsinogen activation [51] and washes out
digestive enzymes from the pancreas [6]. Impaired or de-
creased fluid secretion can lead to pancreatic injury or even
pancreatitis [19, 20, 64]. Yamamoto et al. [81] showed that
low concentrations (0.3–30 mM) of ethanol augmented ductal
fluid secretion stimulated with physiological or pharmacolog-
ical concentrations of secretin, whereas a high concentration
of ethanol (100 mM) completely abolished this effect [81].
However, the cellular mechanisms underlying these responses
to alcohol are unknown.
One of the key players in ductal fluid secretion is the cystic
fibrosis transmembrane conductance regulator (CFTR) Cl−
channel which works closely with SLC26 anion exchangers
to regulate normal ductal HCO3
− and fluid secretion [53, 59,
71, 78]. It is well documented that mutations in the cftr gene
are often associated with pancreatitis [19]; however, little data
are available regarding the effect of ethanol, or its metabolites,
on CFTR function. Recently, Raju et al. demonstrated that
24 h of preincubation of airway epithelial cells with 100 mM
ethanol inhibited CFTR-mediated chloride secretion by direct-
ly affecting cellular cAMP levels [58].
In this article, we show that ethanol, its non-oxidative
metabolites, palmitoleic acid ethyl ester (POAEE) and the
fatty acid (FA) palmitoleic acid (POA), strongly inhibit
CFTR Cl− channel activity via a reduction in intracellular
ATP (ATPi) levels. Importantly, these deleterious effects on
CFTR activity were prevented by increasing cytosolic ATP.
We speculate that supplementation of ATPi in pancreatic
ductal cells may represent a novel therapeutic tool in the
treatment of acute alcohol-induced pancreatitis.
Materials and methods
Capan-1 cell culture
Capan-1 cells were grown in Roswell Park Memorial Institute
(RPMI)-1640 Medium supplemented with 15 % fetal bovine
serum, 1 % penicillin–streptomycin. Cells from passage num-
bers 20–60 were used in this study. For electrophysiological
measurements, 5×105 cells were plated onto 24-mm-diameter
glass coverslips and used for experiments after 3 to 4 days of
culture (~60–80 % confluency).
Isolation of pancreatic ductal cells
Four- to eight-week-old guinea pigs were killed by cervical
dislocation in accordance with protocols approved by the local
ethical board of the University of Szeged. Intra/interlobular
ducts were isolated by enzymatic digestion and microdissec-
tion from the pancreas and then cultured overnight as previ-
ously described [5]. To obtain single pancreatic ductal cells,
cultured ducts were incubated for 50 min at 37 °C in 50 U/ml
elastase dissolved in storage solution (Dulbecco's modified
Eagle's medium containing 3 % (w /v ) bovine serum albumin
(pH 7.4 with NaOH)). The ducts were then washed in a Ca2+/
Mg2+-free Kreb's–Ringer HEPES buffer (pH 7.4) for 10 min
further in order to stop elastase activity. After the incubation,
ducts were teased apart using stainless steel needles. In the
patch clamp experiments, one drop of cell suspension was
placed within a transparent recording chamber, and single
ductal cells were allowed to settle and attach to the bottom
of the chamber for at least 30 min before perfusion was
initiated. In the microfluorometric measurements, one drop
of cell suspension was transferred to a poly-l -lysine-coated
cover slip (24 mm) forming the base of a perfusion chamber.
Cells were then washed continuously with solutions at a rate
of 1.5 or 5–6ml/min in the patch clamp andmicrofluorometric
measurements, respectively. Individual ductal cells were used
within 3–4 h after the isolation.
Whole cell current recording
Patch-clampmicropipettes were pulled from borosilicate glass
capillaries using a P-97 Flaming/Brown micropipette puller
(Sutter Co. Novato, CA, USA) and had resistances between
2.5 and 4 MΩ. Whole cell currents were recorded with
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Axopatch-1D patch clamp amplifier (Molecular Devices-Axon
Instruments, Union City, CA, USA) at 37 °C. The standard
extracellular solution contained (in mM) 145 NaCl, 4.5 KCl, 2
CaCl2, 1 MgCl2, 10 HEPES and 5 glucose (pH 7.4 with
NaOH). The osmolarity of the external solution was
300 mOsm/l. The standard pipette solution contained (in mM)
120 CsCl, 2 MgCl2, 10 HEPES, 5 ethylene glycol-bis(b -
aminoethyl ether)-N ,N ,N8,N8-tetraacetic acid (EGTA) and 1
Na2ATP (pH 7.2 with CsCl). The osmolarity of the pipette
solution was 240 mOsm/l. In some experiments, the ATP
concentration was increased to 2 or 5 mM. After establishing
a high (1–10 GOhm) resistance seal by gentle suction, the cell
membrane was disrupted by further suction or by applying a
1.5-V electrical pulse for 1–5 ms. Membrane currents were
digitized using a 333-kHz analog-to-digital converter
(Digidata 1200, Molecular Devices-Axon Instruments, Union
City, CA, USA) after low-pass filtering at 1 kHz under software
control (PCLAMP 6.0, Molecular Devices-Axon Instruments,
Union City, CA, USA). To obtain current/voltage (I /V) rela-
tionships, the membrane potential (Vm) was held at 0 mV and
then clamped to ±100 mV in 20-mV increments for 500 ms,
with an 800-ms interval between each pulse. Currents were
measured over a 4-ms period starting 495 ms into the voltage
pulse. Mean current amplitudes were calculated at±60 mVand
normalised to cell capacitance (pF).
Measurement of intracellular ATP
Changes in intracellular ATP (ATPi) were estimated using the
Mg2+-sensitive fluorescent dye, Magnesium Green-AM
(MgGreen-AM). Most of the Mg2+ ions in the cells are bound
to ATP. Since ATP has a higher affinity for Mg2+ than ADP,
upon ATP hydrolysis the concentration of cytosolic free Mg2+
increases [47]. Upon binding Mg2+, MgGreen exhibits an
increase in fluorescence emission intensity which allows the
indirect measurement of ATPi. Cells were incubated with
5 μM MgGreen-AM in the presence of 0.05 % pluronic F-
127 in standard HEPES solution (in mM: 130 NaCl, 5 KCl, 1
CaCl2, 1MgCl2, 10 D-glucose and 10 Na-HEPES; pHwas set
to 7.4 with HCl) for 30 min at room temperature. Five to ten
cells (region of interest, ROIs) were then excited with light at a
wavelength of 490 nm, with emitted light monitored at
535 nm. The fluorescence emissions were captured by a
CCD camera and digitized by an Xcellence imaging system
(Olympus, Budapest, Hungary). One ATPi measurement was
obtained per second. Fluorescence signals were normalised to
initial fluorescence intensity (F /F0) and expressed as relative
fluorescence.
Chemicals
Chromatographically pure collagenase was purchased from
Worthington (Lakewood, NJ, USA). Mg-Green was from
Invitrogen (Eugene, OR, USA). Forskolin was obtained from
Tocris (Bristol, UK) andmade up as a 50-mM stock solution in
dimethyl sulphoxide (DMSO). Palmitoleic acid ethyl ester was
purchased fromCayman Chemical (Estonia, Tallinn). All other
chemicals were purchased from Sigma (Budapest, Hungary)
and were of the highest grade available. Palmitoleic acid and
POAEE were made up as a 10-mM stock solution in DMSO,
and on the day of the experiment, an appropriate quantity of the
stock POAwas dissolved in Krebs or HEPES. Emulsification
of POAwas achieved by sonication.
Statistics
Data are expressed as means±SEM. Significant difference
between groups was determined by Student's t -test or by
analysis of variance. P values≤0.05 were accepted as signif-
icantly different.
Results
Measurement of CFTR conductance in guinea pig PDECs
Our experimental conditions were designed to selectively study
CFTR channel activity in PDECs as described previously [50].
In order to block potassium conductances, we used a CsCl-rich
pipette solution, whereas Ca2+-activated Cl− currents were
inhibited by using 5 mM intracellular EGTA to lower Ca2+
levels to ~10 nM. After establishing a whole cell recording, a
small resting current was observed (23±2.5 pA/pF at±60 mV;
Fig. 1a—i), with a mean reversal potential of −5.6 mV, which is
very close to the Cl− equilibrium potential (~ −5.7 mV; Fig. 1b).
Administration of 5 μM forskolin (a cAMP agonist) to the
bathing solution increasedwhole cell currents by approximately
tenfold in 70 % of cells (Fig. 1a—ii). The forskolin-activated
currents were voltage-independent with a linear I /V relationship
(Fig. 1b) and decreased after removal of forskolin from the
external solution (Fig. 1a—ii). To confirm that the basal and
stimulated currents were both mediated by CFTR, we tested
CFTRinh-172, a potent inhibitor of the channel [40, 46].
Administration of 10 μM CFTRinh-172 reversibly and signifi-
cantly blocked the basal currents by 58.2±5.7 % (at+60 mV;
Fig. 1c) and forskolin-stimulated currents by 66.6±
6.4 % (at+60 mV; Fig. 1d), providing further evidence
that under our experimental conditions the whole cell
currents were due to CFTR.
Ethanol increases the basal but inhibits
the forskolin-stimulated CFTR currents
We examined the effect of 1–100 mM ethanol on both basal
and forskolin-stimulated whole cell currents. Exposing duct
cells to 1 mM ethanol had no significant effect on basal or
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forskolin-activated CFTR currents, even after 15 min of ad-
ministration (Fig. 2c, f). Increasing the ethanol concentration
to 10 mM significantly increased the basal current by 32.6±
10.2 % after 15 min of administration (at+60 mV; Fig. 2a–c),
whereas 100 mM ethanol induced a robust increase within
5 min (110.1±7.2 % at+60 mV; Fig. 2a–c). In contrast, both
10 and 100 mM ethanol blocked the forskolin-stimulated
whole cell currents (31.4±9.6 and 66.5±5.4 %, respectively,
after 15 mins at +60 mV; Fig. 2d–f). Both the stimulatory and
inhibitory effects of ethanol were reversible on washout. In
addition, block by ethanol was not voltage dependent
(Fig. 2d, e).
We next investigated the mechanism by which ethanol
exerts its effects on CFTR. Since the plasma membrane is
permeable to ethanol, it can diffuse into the cell and bind to
water molecules which will disrupt the osmotic environment
and lead to cellular dehydration. Under these conditions, the
flow of ions and water could change. In order to decide
whether ethanol has an indirect osmotic effect on CFTR or
whether it can directly affect the channel or its regulation, we
exposed cells to mannitol, a cell-impermeable molecule, in
order to osmotically shrink the cells. An osmotically equiva-
lent concentration of mannitol (177 mM) increased the basal
CFTR currents by fourfold (from 24.4±3.5 to 97.5±22 pA/pF
at +60mV; Fig. 3a). The rate of the mannitol-induced increase
in whole cell currents was similar to the rate of ethanol-
induced increase, indicating that the stimulatory effect of a
high concentration of ethanol on the basal current is likely to
be via an osmotic effect. In contrast to ethanol, mannitol did
not decrease but significantly increased the forskolin-
stimulated currents by 49.7±10.2 % (after 15 mins at +
60 mV; Fig. 3b), suggesting that the inhibitory effect of
ethanol is independent of its osmotic effect.
Effects of ethanol metabolites on basal
and forskolin-stimulated CFTR currents
Acetaldehyde (Ac) is the end product of oxidative ethanol
degradation, whereas the non-oxidative degradation of etha-
nol produces fatty acid ethyl esters (FAEEs). Using the same
conditions as the ethanol experiments, neither 1 nor 5 mMAc
had any effect on basal or forskolin-stimulated CFTR currents
(data not shown, n =5). POAEE, an unsaturated non-oxidative
metabolite of ethanol, also had no effect on the basal currents
over the concentration range of 10–200 μM (Fig. 4a–c).
However, in marked contrast, 200 μM POAEE was able to
block the forskolin-stimulated CFTR currents by 56.1±
12.3 % after 15 min of exposure (at+60 mV; Fig. 4d–f).
The unsaturated FA, POA, at low concentrations (10 μM)
did not affect the basal or forskolin-stimulated CFTR currents
(Fig. 5c, f). However, at higher concentrations (100 and
200 μM), POA induced a dose-dependent and significant
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Fig. 1 CFTRCl− currents in single native guinea pig PDECs.Whole cell
currents were obtained by applying 500-ms-duration voltage-clamp steps
ranging between −100 and +100 mV in 20-mV steps from a holding
potential of 0 mV in a normal bath solution with a CsCl-rich pipette
solution. a Representative whole cell currents recorded before stimula-
tion (i), during stimulation with forskolin (5 μM) (ii) and after washout of
forskolin from the bath (iii). b Current/voltage (I /V) relationships were
obtained by measuring currents over a 4-ms period starting 495 ms into
the voltage pulse. The currents were measured under basal conditions
(diamonds), during exposure to forskolin (squares) and after washout of
forskolin from the bath (triangles). c , d Summary of current densities
(measured at+60 mV) in basal (c) and in forskolin-stimulated (d) cells in
the presence of CFTR inhibitor, CFTRinh-172 (10 μM). The current
densities have been normalised to the cell input capacitance. Data are
presented as means±SEM. *p <0.05 vs forskolin, n =7–10
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Fig. 2 Effect of ethanol on basal and forskolin-stimulated CFTR currents
in single native guinea pig PDECs. Whole cell currents were recorded as
described in Fig. 1. Basal conditions (a–c): a representative whole cell
currents recorded under basal conditions (i), after 15 min from adminis-
tration of ethanol (100 mM) (ii) and after washout of ethanol from the bath
(iii). b Current–voltage (I/V) relationships were obtained as described in
Fig. 1. The currents were measured under basal conditions (diamonds),
during 15min of exposure to 100mM ethanol (squares) and after washout
of ethanol from the bath (triangles). c Summary of current densities
(measured at +60 mV) in control, in the presence of ethanol (1, 10 and
100 mM) and after washout of ethanol from the bath. The current densities
have been normalised to the cell input capacitance. Data are presented as
means±SEM. *p<0.05 vs control, n=10–13. Forskolin-stimulated cells
(d–f): d representative whole cell currents recorded before stimulation (i),
during stimulation with forskolin (5 μM) (ii), in the presence of 100 mM
ethanol (15 min) (iii), after removal of ethanol from the bath (iv) and after
washout of forskolin from the bath (v). e Current/voltage (I/V) relation-
ships were obtained as described in Fig. 1. The currents were measured
under basal conditions (diamonds), during stimulation with forskolin in
the absence (squares) and presence (triangles) of ethanol (100 mM) and
after washout of forskolin from the bath (circles). f Summary of current
densities (measured at+60 mV) in control, in forskolin-stimulated cells, in
the presence of ethanol (1, 10 and 100 mM, respectively) and after
washout of forskolin and ethanol from the bath. The current densities have
been normalised to the cell input capacitance. Data are presented as means
±SEM. *p<0.05 vs forskolin, n=10–13. EtOH ethanol
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decrease in both the basal currents (63.6±5.2 and 68.4±5.5 %
at+60 mV, respectively; Fig. 5a–c) and forskolin-stimulated
CFTR currents (72.1±4.2 and 70.1±6.7 % at+60 mV,
respectively; Fig. 5d–f). The inhibitory effect of POAEE
and POA (100 and 200 μM) reached a maximum after
5 and 15 min of administration, respectively, and were
always reversible on washout.
The formation of FAEEs from ethanol and FAs is catalysed
by the enzyme FAEE synthase [37], whereas FAEE hydrolase
is responsible for the reverse reaction. The highest activities of
FAEE synthases/hydrolases are found in the liver and pancre-
as [17]. A number of FAEE synthases have been identified,
and among them pancreatic cholesterol ester synthase and
pancreatic carboxylester synthase have been shown to possess
some FAEE-synthesizing activity in the pancreas [61, 74].
Although several studies have demonstrated that FAEEs are
involved in organ injury, we wanted to test whether the
inhibitory effect of POAEE depended on its hydrolysis. For
this, we treated the cells with 200 μM bis-(4-nitrophenyl)
phosphate (BNPP), an inhibitor of FAEE hydrolase [17].
Fifteen minutes of treatment with this agent did not change
the basal or forskolin-stimulated whole cell currents, indicat-
ing that BNPP alone has no effect on CFTR activity. In
contrast, BNPP treatment almost completely abolished the
inhibitory effect of POAEE on forskolin-stimulated currents
(187.3±12.9 to 141.6±4.7 pA/pF; 15 min of administration of
POAEE at+60 mV), strongly suggesting that formation of
POA is a crucial step in the inhibitory effect of POAEE/
ethanol.
Ethanol, POAEE and POA cause ATPi depletion in PDECs,
which is linked to CFTR inhibition
We next investigated the intracellular mechanism by which
ethanol, and its non-oxidative metabolites, exerts its inhibitory
effect on CFTR. Previous studies have shown that ethanol and
monounsaturated FAs, such as POA, promote opening of the
permeability transition pore, which leads to mitochondrial
depolarization and finally cell death [22, 36]. Since no data
are available regarding the effect of FAs on mitochondrial
function in PDECS, we investigated the effect of ethanol,
and its non-oxidative metabolites, on mitochondrial injury
using a microfluorometric technique. PDECs were loaded with
the Mg2+-sensitive fluorescent dye, MgGreen-AM, which al-
lows an indirect measurement of ATPi [7]. Administration of
100mM ethanol caused a small ATPi depletion in 75% of cells
(Fig. 6a–c), whereas POA or POAEE (200 μM) induced a
marked increase in MgGreen fluorescence intensity, which
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Fig. 3 Effect of mannitol on basal and forskolin-stimulated CFTR cur-
rents in single native guinea pig PDECs. Summary of current densities
(measured at+60 mV) in basal (a) and forskolin-stimulated cells (b) in
the presence of 177 mM mannitol. The current densities have been
normalised to the cell input capacitance. Data are presented as means±
SEM. *p<0.05 vs control, **p <0.05 vs forskolin, n =6–7 Fig. 4 Effect of POAEE on basal and forskolin-stimulated CFTR
currents in single native guinea pig PDECs. Whole cell currents were
recorded as described in Fig. 1. Basal conditions (a–c): a representative
whole cell currents recorded under basal conditions (i), after 5 min of
administration of POAEE (200 μM) (ii), after 10 min administration of
POAEE (200 μM) (iii ), after 15 min of administration of POAEE
(200 μM) (iv ) and after washout of POAEE from the bath (v ). b
Current–voltage (I /V ) relationships were obtained as described in
Fig. 1. The currents were measured under basal conditions (diamonds),
during 15 min of exposure to 200 μM POAEE (squares) and after
washout of POAEE from the bath (triangles). c Summary of current
densities (measured at+60mV) in control, in the presence of POAEE (10,
100 and 200 μM, respectively) and after washout of POAEE from the
bath. The current densities have been normalised to the cell input
capacitance. Data are presented as means±SEM; n =9–12. Forskolin-
stimulated cells (d–f): d representative whole cell currents recorded
before stimulation (i), during stimulation with forskolin (5 μM) (ii), in
the presence of 200 μM POAEE (15 min) (iii), after removal of POAEE
from the bath (iv) and after washout of forskolin from the bath (v). e
Current–voltage (I /V) relationships were obtained as described in Fig. 1.
The currents were measured under basal conditions (diamonds), during
stimulation with forskolin in the absence (squares ) and presence
(triangles) of 200 μM POAEE (15 min) and after washout of forskolin
from the bath (circles). f Summary of current densities (measured at+
60 mV) in control, in forskolin-stimulated cells, in the presence of
POAEE (10, 100 and 200 μM, respectively) and after washout of
forskolin and POAEE from the bath. The current densities have been
normalised to the cell input capacitance. Data are presented as means±
SEM. *p<0.05 vs forskolin, n =8–10
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reached a plateau about 5 min after the administration of the
metabolites (Fig. 6a–c).
We have previously shown that inhibitors of both oxidative
and glycolytic metabolism, carbonyl cyanide m -chlorophenyl
hydrazone (CCCP; 100 μM) and 2-deoxyglucose/
iodoacetamide (DOG/IAA, 10 mM), respectively, caused a
marked and irreversible depletion of ATPi in guinea pig pan-
creatic ductal cells [42]. In order to decide whether the
inhibitory effect of ethanol, POA and POAEE on CFTR was
linked to the depletion of ATPi, we tested the effect of CCCP/
DOG/IAA administration on CFTR currents and found that
this combination of inhibitors blocked both the basal (Fig. 6d)
and forskolin-stimulated currents (Fig. 6e) in a similar manner
to ethanol, POA and POAEE. After the removal of CCCP/
DOG/IAA from the external solution, the currents did not
return to the initial levels, indicating that CCCP/DOG/IAA
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Fig. 5 Effect of POA on basal and forskolin-stimulated CFTR currents in
single native guinea pig PDECs. Whole cell currents were recorded as
described in Fig. 1. Basal conditions (a–c): a representative whole cell
currents recorded under basal conditions (i), after 5 min of administration
of POA (200 μM) (ii), after 10 min of administration of POA (200 μM)
(iii), after 15 min of administration of POA (200 μM) (iv) and after
washout of POA from the bath (v). b Current–voltage (I /V) relationships
were obtained as described in Fig. 1. The currents were measured under
basal conditions (diamonds), during 15 min of exposure to 200 μMPOA
(squares) and after washout of POA from the bath (triangles). c Sum-
mary of current densities (measured at+60mV) in control, in the presence
of POA (10, 100 and 200 μM, respectively) and after washout of POA
from the bath. The current densities have been normalised to the cell input
capacitance. Data are presented as means±SEM. *p <0.05 vs control, n =
8–10. Forskolin-stimulated cells (d–f): d representative whole cell
currents recorded before stimulation (i ), during stimulation with
forskolin (5 μM) (ii), in the presence of 200 μM POA (15 min)
(iii), after removal of POA from the bath (iv) and after washout of
forskolin from the bath (v). e Current–voltage (I /V) relationships were
obtained as described in Fig. 1. The currents were measured under
basal conditions (diamonds), during stimulation with forskolin in the
absence (squares) and presence (triangles) of 200 μM POA (15 min)
and after washout of forskolin from the bath (circles). f Summary of
current densities (measured at+60 mV) in control, in forskolin-stimu-
lated cells, in the presence of POA (10, 100 and 200 μM, respective-
ly) and after washout of forskolin and POA from the bath. The current
densities have been normalised to the cell input capacitance. Data are
presented as means±SEM. *p <0.05 vs forskolin, n=8–10
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irreversibly inhibit CFTR, probably due to the maintained
depletion of ATPi.
Intracellular ATP supplementation reverses the inhibitory
effect of ethanol, POAEE and POA on CFTR activity
in PDECs
To investigate further the apparent relationship between the
inhibitory effect of ethanol, POA and POAEE on CFTR
channel activity and depletion of ATPi, we tested whether
raising ATPi levels in PDECswould result in a better tolerance
to these agents. Increasing the ATPi concentration in the
pipette solution from 1 mM to either 2 or 5 mM did not
produce a detectable alteration in the size, or properties, of
the basal or forskolin-stimulated CFTR currents (data not
shown), suggesting that ATP was not limiting for CFTR
activity under all conditions. Next, we studied the effect of
100 mM ethanol, 200 μMPOAEE or 200 μMPOA on CFTR
currents in the presence of 2 mM ATP in the pipette.
Supplementation of the pipette solution with 2 mM ATP did
not influence the effects of ethanol or its non-oxidative me-
tabolites on CFTR currents (data not shown). In contrast,
increasing the ATP concentration to 5 mM completely
prevented the inhibitory effect of ethanol (Fig. 7a) and
POAEE (Fig. 7b) on forskolin-stimulated currents, as well as
the effect of POA on the basal (Fig. 7c) and forskolin-
stimulated CFTR currents (Fig. 7d). These results indicate
that inhibition of CFTR by ethanol//POAEE/POA is likely
due to a reduction of ATPi and/or to a change in ATPi inter-
action with CFTR.
Intracellular ATP supplementation in human PDECs
To extend these studies to human PDECs, we used a human
ductal adenocarcinoma cell line, Capan-1, which has been
shown to express CFTR [11], and studied the effect of ATPi
supplementation on the inhibitory effect of POA. Similar to
guinea pig PDECs, 200 μM POA decreased the forskolin-
stimulated CFTR currents by 69.7±3.2 % (from 86.7±7.1 to
27.7±6.8 pA/pF at+60mV; Fig. 8a, b). Administration of 2mM
intracellular ATP did not affect the inhibitory effect of POA;
however, in the presence of 5 mM intracellular ATP, this inhi-
bition was significantly reduced to 36.1±3.2 % (Fig. 8a, b).
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Discussion
Long-term use of alcohol is associated with several gastroin-
testinal [62, 73] and neurological [48] disorders and is one of
the leading causes of certain types of cancer [65]. Therefore, a
number of studies have investigated the effects of ethanol on
various tissues. In hepatocytes, ethanol (100 mM) decreases
cell viability and induces lipid peroxidation [82], whereas
chronic ethanol feeding damages the hepatic mitochondria in
rats [10]. In the heart, chronic alcohol intake elevates blood
pressure and leads to alcohol-induced heart muscle disease
[39]. It has also been shown that a very high concentration of
ethanol (1.7 M) inhibits intracellular protease activities in
human brain, liver and muscle in vitro [44]. In addition,
neuroradiological studies have demonstrated that the brain
undergoes loss of both white and gray matter in chronic
alcoholics [9].
The effect of ethanol on the pancreas is also well charac-
terized since excessive alcohol consumption is one of the
leading causes of both chronic and acute pancreatitis [21].
One of the major functional cell types of the exocrine pancreas
is the ductal cell. In these cells, the CFTR Cl− channel works
closely with apical Cl−/HCO3
− exchangers to provide a daily
supply of~2.5 L of a HCO3
−-rich fluid secretion, which is
essential for normal exocrine gland function [70, 71, 78].
Mutations in the cftr gene are often associated with pancrea-
titis. Several loss of function CFTR mutations have been
shown to impair ductal fluid and HCO3
− secretion and lead
to the development of acute [12, 35, 56] or chronic pancreatitis
[12, 31, 56, 60, 72] or are responsible for certain cases of
idiopathic pancreatitis [13, 14]. In addition, the frequency of
CFTR mutations in patients with alcoholic pancreatitis is
twice as high compared to the general population [67].
In contrast, the functional insufficiency of normal CFTR
and its role in alcoholic pancreatitis is less characterized. In the
present study, we show that ethanol, its non-oxidative metab-
olite POAEE and the FA POA strongly inhibit CFTR Cl−
channel activity in guinea pig PDECs when measured using
the whole cell configuration of the patch clamp technique. We
demonstrate that 1 mM ethanol (a blood alcohol level reached
during moderate social drinking) had no effect on basal or
forskolin-stimulated CFTR channel activity. However, at
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higher concentrations such as 10 or 100 mM (which is equiv-
alent to a lethal blood alcohol level in humans [69]), ethanol
increased the basal and decreased the forskolin-stimulated
CFTR currents. The present observation that low concentra-
tions of ethanol (1 mM) had no effect whereas high concen-
trations (10 and 100 mM) inhibit secretagogue-stimulated
CFTR activity is in agreement with previous observations that
alcohol exerts dose-related effects on the pancreas [18]. Using
an equivalent concentration of mannitol, we show that the
stimulatory effect of ethanol is likely to be due to an osmotic
effect, whereas the inhibitory effect is independent of any the
change in osmolarity.
Several experimental studies have shown a key role of
ethanol metabolites in the development of pancreatitis [80].
The oxidative metabolism of ethanol is catalysed by alcohol
dehydrogenase and predominantly occurs in hepatocytes.
However, it has been postulated that pancreatic acinar cells
are also able to oxidatively metabolise a significant amount of
ethanol [23, 25]. It has been shown that Ac inhibits NF-κB
binding activity [23] and cholecystokinin-induced secretion
[63] in isolated rat pancreatic acinar cells and, at higher
concentrations, causes morphological alterations in the rat
pancreas [41]. In our study, Ac had no effect on CFTR activity
or on ATPi; furthermore, it did not cause any morphological
changes in ductal cells even at high concentrations (5 mM),
indicating that PDECs are probably not involved in the toxic
effect of Ac in the pancreas.
In contrast to oxidative metabolism, the pancreas has a very
high capacity to metabolise ethanol through a non-oxidative
pathway [26], and consequently the concentration of these
metabolites is higher in the pancreas than in any other organ
[38]. In addition, FAEE synthase activity [3], the key enzyme
which catalyse FAEE production, is significantly higher in the
pancreas than in the liver [80]. The effects of non-oxidative
ethanol metabolites on the pancreas have been widely inves-
tigated. At low concentrations, FAEEs (50 μM) are able to
induce pancreatic injury [24], whereas at higher concentra-
tions (200 μM) they cause toxic calcium signalling in acinar
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cells and disrupt the mitochondrial oxidative chain, which
leads to ATPi depletion and finally cell death [15, 16]. In
addition, the pivotal role of FAEEs in the pathophysiology
of alcoholic pancreatitis is also supposed by the fact that high
concentrations of FAEEs have been detected in the pancreas at
autopsy after acute alcohol intoxication and in chronic alco-
holics [38]. Here we show for the first time that the unsaturat-
ed FA POA and its estererized form POAEE reversibly and
time-dependently inhibit CFTR activity in PDECs. The CFTR
Cl− channel is a member of ATP-binding cassette (ABC)
transporter superfamily and is activated by protein kinase A,
a cyclic AMP-activated kinase. Similar to other ABC trans-
porters, CFTR also binds and hydrolyses ATP in order to drive
conformational rearrangements of its transmembrane domains
[8, 32, 77], which in the case of CFTR leads to the opening
and closing of the channel pore. Thus, a supply of ATP is
essential for CFTR function, and in the absence of ATP the
activity of CFTR dramatically decreases [1, 30]. Since FAs
and FAEEs have previously been shown to cause ATP deple-
tion in rat pancreatic acinar cells [16], and alveolar macro-
phages [54], we investigated if ATP depletion could underlie
the effects of ethanol, POAEE and POA on CFTR activity in
PDECs. Our results show that all three compounds decrease
the level of ATPi in the ductal cells (Fig. 6). POA caused a
significantly greater decrease in ATPi than POAEE. In addi-
tion, longer administration of POA did not cause a further
increase in ATPi (as based on Mg-Green fluorescence inten-
sity), indicating that 200 μM POA likely induced nearly
complete ATPi depletion in PDECs. Consistent with this,
inhibition of glycolytic and mitochondrial ATP production
reduced CFTR currents to a similar degree to that caused by
ethanol, POA and POAEE, which strongly suggests that de-
pletion of ATPi is a key step in the inhibitory effect of these
agents on CFTR.
As further support for the pivotal role of ATPi in the
response to ethanol and its metabolites, we show that admin-
istration of ATPi back to the cell via the patch pipette almost
completely abolished the inhibitory effect of these agents on
CFTR activity (Fig. 7). Similar results were found in Capan-1
cells, where supplementation of ATPi was also able to de-
crease the inhibitory effect of POA on CFTR. Whether ATP
depletion prevents protein kinase A-dependent phosphoryla-
tion of CFTR and/or ATP binding to CFTR to support channel
gating requires further investigation.
Recent studies on the pathophysiology of pancreatitis have
shown that mitochondrial damage and ATP depletion play a
key role in the development of the disease [16, 43, 55]. In
acinar cells, FAs cause toxic, sustained calcium signals, which
impair mitochondrial function and ATP production [16, 55].
In the absence of ATP, the Ca2+-activated ATPases, both on
the endoplasmic reticulum (ER) and the plasma membrane,
are not able to pump calcium into the ER or out of the cell,
which leads to a sustained intracellular calcium rise and
eventually cell death. Restoration of ATPi decreased these
toxic calcium signals [16]. Recently, we characterized the
effect of bile acids, another major cause of pancreatitis, on
ductal fluid secretion [29, 33, 42, 75, 76] and showed that
high concentrations (1 mM) of the non-conjugated bile
acid, chenodeoxycholate, inhibit bicarbonate secretion and
cause severe mitochondrial damage in guinea pig PDECs
[28, 42, 43, 75], which was not directly related to a
sustained rise in cytosolic Ca2+.
Taken together, we show for the first time that high con-
centrations of ethanol, POAEE and POA all strongly inhibit
epithelial CFTR channel activity through depletion of ATPi.
Importantly, these deleterious effects of ethanol and its me-
tabolites could be prevented by maintaining cytosolic ATP
levels. Since the CFTR Cl− channel plays an essential role in
ductal electrolyte and fluid secretion, we hypothesise that
functional inhibition of this channel may be involved in the
pathogenesis of alcoholic pancreatitis. Because restoration of
the intracellular energetic pool by ATP supplementation main-
tains CFTR function in the presence of these metabolites, it
may represent a potential novel therapeutic option in the
treatment of pancreatitis.
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BACKGROUND & AIMS: The effects of trypsin on pan-
creatic ductal epithelial cells (PDECs) vary among species
and depend on the localization of proteinase-activated
receptor 2 (PAR-2). We compared PAR-2 localization in
human and guinea-pig PDECs, and used isolated guinea
pig ducts to study the effects of trypsin and a PAR-2
agonist on bicarbonate secretion. METHODS: PAR-2 lo-
calization was analyzed by immunohistochemistry in
guinea pig and human pancreatic tissue samples (from 15
patients with chronic pancreatitis and 15 without pancre-
atic disease). Functionally, guinea pig PDECs were studied
by microperfusion of isolated ducts, measurements of
intracellular pH and intracellular Ca2 concentration, and
patch clamp analysis. The effect of pH on trypsinogen
autoactivation was assessed using recombinant human
cationic trypsinogen. RESULTS: PAR-2 localized to the
apical membrane of human and guinea pig PDECs. Tryp-
sin increased intracellular Ca2 concentration and intra-
cellular pH and inhibited secretion of bicarbonate by the
luminal anion exchanger and the cystic fibrosis trans-
membrane conductance regulator (CFTR) Cl channel.
Autoactivation of human cationic trypsinogen accelerated
when the pH was reduced from 8.5 to 6.0. PAR-2 expres-
sion was strongly down-regulated, at transcriptional and
protein levels, in the ducts of patients with chronic pan-
creatitis, consistent with increased activity of intraductal
trypsin. Importantly, in PAR-2 knockout mice, the effects
of trypsin were markedly reduced. CONCLUSIONS:
Trypsin reduces pancreatic ductal bicarbonate secre-
tion via PAR-2–dependent inhibition of the apical
anion exchanger and the CFTR Cl channel. This
could contribute to the development of chronic pan-
creatitis by decreasing luminal pH and promoting
premature activation of trypsinogen in the pancreatic
ducts.
Keywords: Acinar Cells; Ductal Epithelium; Animal Model;
Pancreatic Enzymes.
Trypsinogen is the most abundant digestive proteasein the pancreas. Under physiologic conditions,
trypsinogen is synthesized and secreted by acinar cells,
transferred to the duodenum via the pancreatic ducts, and
then activated by enteropeptidase in the small intestine.1
There is substantial evidence that early intra-acinar2,3 or
luminal4,5 activation of trypsinogen to trypsin is a key and
common event in the development of acute and chronic
pancreatitis. Importantly, almost all forms of acute pan-
creatitis are due to autodigestion of the gland by pancre-
atic enzymes.6
Several studies have shown that trypsin stimulates en-
zyme secretion from acinar cells via proteinase-activated
receptor 2 (PAR-2),7,8 whereas the effect of trypsin on
pancreatic ductal epithelial cells (PDECs) is somewhat
controversial. Trypsin activates ion channels in dog
PDECs9 and stimulates bicarbonate secretion in the CA-
PAN-1 human pancreatic adenocarcinoma cell line,10
whereas it dose-dependently inhibits bicarbonate efflux
from bovine PDECs.11 The effect of trypsin differs not
only among species, but also with respect to the localiza-
tion of PAR-2. When PAR-2 is localized to the basolateral
membrane and activated by trypsin, the result is stimula-
tion of bicarbonate secretion.9,10 In contrast, when the
receptor is localized to the luminal membrane, the effect
is inhibition.11 Interestingly, there are no data available
concerning the effects of trypsin on guinea pig PDECs
which, in terms of bicarbonate secretion, are an excellent
model of human PDECs.12
The human pancreatic ductal epithelium secretes an
alkaline fluid that may contain up to 140 mmol/L
NaHCO3.12,13 The first step in HCO3 secretion is the
accumulation of HCO3 inside the cell, which is driven by
basolateral Na/HCO3 cotransporters, Na/H exchang-
ers, and H-adenosine triphosphatases.12,13 Only 2 trans-
porters have been identified on the apical membrane of
Abbreviations used in this paper: BAPTA-AM, 1,2-bis(o-aminophe-
noxy)ethane-N,N,N=,N=-tetraacetic acid; CFTR, cystic ﬁbrosis transmem-
brane conductance regulator Cl channel; CFTRinh-172, CFTR inhibitor-
172; [Ca2]i, intracellular Ca2 concentration; H2DIDS, dihydro-4,4=-
diisothiocyanostilbene-2,2=-disulfonic acid; PAR-2, proteinase-activated
receptor-2; PAR-2-AP, PAR-2 activating peptide; PAR-2-ANT, PAR-2 an-
tagonist; PDEC, pancreatic ductal epithelial cell; pHi, intracellular pH;
pHL, luminal pH; SBTI, soybean trypsin inhibitor; SLC26, solute carrier
family 26.
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cells in the proximal ducts that are the major sites of
HCO3 secretion: cystic fibrosis transmembrane conduc-
tance regulator (CFTR) and the solute carrier family 26
(SLC26) anion exchangers.12,13 How these transporters act
in concert to produce a high HCO3 secretion is contro-
versial.14 Most likely, HCO3 is secreted through the an-
ion exchanger until the luminal concentration reaches
about 70 mmol/L, after which the additional HCO3
required to raise the luminal concentration to 140
mmol/L is transported via CFTR.15,16
The role of PAR-2 in experimental acute pancreatitis is
also controversial and highly dependent on the model of
pancreatitis studied. PAR-2 was found to be protective
in secretagogue-induced pancreatitis in mice7,17–19 and
rats.20 However, PAR-2 is clearly harmful when pancreati-
tis is evoked by the clinically more relevant luminal ad-
ministration of bile salts in mice.17
In this study, we show for the first time that (1) PAR-2
is localized to the apical membrane of the human proxi-
mal PDECs, (2) the localization of PAR-2 in the guinea pig
pancreas is identical to that in the human gland, (3)
trypsin markedly reduces bicarbonate efflux through a
dihydro-4,4=-diisothiocyanostilbene-2,2=-disulfonic acid
(H2DIDS)-sensitive apical SLC26 anion exchanger and
strongly inhibits CFTR, (4) a decrease in pH within the
ductal lumen will strongly accelerate the autoactivation of
trypsinogen, and (5) trypsin down-regulates PAR-2 expres-
sion at both transcriptional and protein levels in PDECs
of patients with chronic pancreatitis.
Materials and Methods
A brief outline of the materials and methods is given in
the following text. For further details, please see Supplementary
Materials and Methods.
Solutions
The compositions of the solutions used for microfluo-
rimetry are shown in Table 1.
Isolation of Pancreatic Ducts and Individual
Ductal Cells
Small intralobular proximal ducts and individual ductal
cells were isolated from guinea pigs or PAR-2 wild-type (PAR-
2/) and knockout (PAR-2/) mice with a C57BL6 back-
ground by microdissection as described previously.21
Measurement of Intracellular pH and Ca2
Concentration
Intracellular pH (pHi) and calcium concentration ([Ca2]i)
were estimated by microfluorimetry using the pH- and Ca2-sensi-
tive fluorescent dyes 2,7-bis-(2-carboxyethyl)-5-(and-6-)carboxyfluo-
rescein, acetoxymethyl ester (BCECF-AM) and 2-(6-(bis(carboxy-
methyl)amino)-5-(2-(2-(bis(carboxymethyl)amino)-5-methylphenoxy)-
ethoxy)-2-benzofuranyl)-5-oxazolecarboxylic acetoxymethyl ester
(FURA 2-AM), respectively.
Microperfusion of Intact Pancreatic Ducts
The luminal perfusion of the cultured ducts was per-
formed as described previously.22
Electrophysiology
CFTR Cl channel activity was investigated by whole cell
patch clamp recordings on guinea pig single pancreatic ductal
cells.
Measuring Autoactivation of Trypsinogen
Autoactivation of human cationic trypsinogen was de-
termined in vitro at pH values ranging from 6.0 to 8.5. Experi-
mental details are described in Supplementary Materials and
Methods.
Immunohistochemistry
Five guinea pig, 2 PAR-2/, 2 PAR-2/, and 30 human
pancreata were studied to analyze the expression pattern of
PAR-2 protein. Relative optical densitometry was used to quan-
tify the protein changes in the histologic sections. Patients’ data
and the full methods are described in Supplementary Supple-
mentary Materials and Methods.
Real-Time Reverse-Transcription Polymerase
Chain Reaction
RNA was isolated from 30 human pancreata. Following
reverse transcription, messenger RNA (mRNA) expression of
PAR-2 and -actin was determined by real-time polymerase
chain reaction analysis.
Results
Expression of PAR-2 in Guinea Pig and
Human Pancreata
PAR-2 was highly expressed in the luminal mem-
brane of small intralobular and interlobular ducts (Figure
1A [i]; cuboidal epithelial cells forming the proximal pan-
creatic ducts) but was almost undetectable in the larger
interlobular ducts (Figure 1A [ii]; columnar epithelial cells
forming the distal pancreatic ducts). The localization of
PAR-2 in the human pancreas was identical to that in the
guinea pig gland (Figure 1A [iv–vi]). Measurements of
relative optical density confirmed the significant differ-
ences between the expression of PAR-2 in small intralob-
ular and interlobular ducts and the larger interlobular
ducts in both species (Figure 1C).
Table 1. Composition of Solutions for Microfluorimetry
Studies
Standard Standard Cl-free Ca2-free
HEPES HCO3 HCO3 HEPES
NaCl 130 115 132
KCl 5 5 5
MgCl2 1 1 1
CaCl2 1 1
Sodium HEPES 10 10
Glucose 10 10 10 10
NaHCO3 25 25
Sodium gluconate 115
Magnesium gluconate 1
Calcium gluconate 6
Potassium sulfate 2.5
NOTE. Values are concentrations in mmol/L.
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Luminal Administration of PAR-2-AP and
Trypsin Induces Dose-Dependent [Ca2]i
Signals
Because PAR-2 expression was detected only on the
luminal membrane of intralobular duct cells, we used the
microperfusion technique to see whether these receptors
can be activated by PAR-2 agonists. First, the experiments
were performed at pH 7.4 to understand the effects of
trypsin and PAR-2 under quasi-physiologic conditions
(Figure 2). The fluorescent images in Figure 2A clearly
show that luminal administration of PAR-2 activating
peptide (PAR-2-AP) increased [Ca2]i in perfused pancre-
atic ducts. The [Ca2]i response was dose dependent and
consisted of a peak in [Ca2]i that decayed in the contin-
ued presence of the agonist, possibly reflecting PAR-2
inactivation or depletion of intracellular Ca2 stores (Fig-
ure 2B). Pretreatment of PDECs with 10 mol/L PAR-2
antagonist (PAR-2-ANT) for 10 minutes completely
blocked the effects of 10 mol/L PAR-2-AP on [Ca2]i
(Figure 2A and C). Removal of extracellular Ca2 had no
effect on the increase in [Ca2]i evoked by luminal admin-
istration of 10 mol/L PAR-2-AP; however, preloading
ducts with the calcium chelator 1,2-bis(o-aminophe-
noxy)ethane-N,N,N=,N=-tetraacetic acid (BAPTA-AM) at 40
mol/L totally blocked the response (Figure 2A and C).
Trypsin also induced a dose-dependent elevation in
[Ca2]i similar to that evoked by PAR-2-AP (Figure 2E and
F). Addition of 5 mol/L soybean trypsin inhibitor
(SBTI), 10 mol/L PAR-2-ANT, and 40 mol/L
BAPTA-AM totally blocked the increase in [Ca2]i (Figure
2D and F). These data show that trypsin activates PAR-2
on the luminal membrane of the duct cell, which leads to
release of Ca2 from intracellular stores and an elevation
of [Ca2]i.
Because the pH of pancreatic juice can vary between
approximately 6.8 and 8.0,23,24 we also evaluated the ef-
fects of trypsin and PAR-2-AP on [Ca2]i at these pH
values (Supplementary Figures 1 and 2, respectively). The
Figure 1. Localization of PAR-2 on human and guinea pig pancreatic ducts. Light micrographs of (A [i–iii]) guinea pig and (A [iv–vi]) human pancreas
are shown. (i) PAR-2 is localized to the luminal membrane of PDECs in small intralobular and interlobular ducts (original magnification 400). (ii) Large
interlobular ducts do not express PAR-2 (original magnification 200). (iii) No primary antiserum (original magnification 200). (iv and v) Sections from
human pancreas exhibit a similar localization of PAR-2 compared with the guinea pig gland (original magnification 400 and 200). (vi) No primary
antiserum (original magnification 200). (B) Western blot analysis was used to determine the specificity of the PAR-2 antibody. Polyclonal anti–PAR-2
showed a single 44-kilodalton band. (C) Quantitative measurement of relative optical densities (RO-Density) of small intralobular and interlobular
ducts (A.i,iv), and large interlobular ducts (A.ii,v) is shown. n 12. *P .05 vs A.ii or A.v, respectively. Scale bar 50 m for A (i, iv) and 100 m for
A (ii and iii) and A (v and vi).
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elevations of [Ca2]i at pH 6.8 and 8.0 were generally very
similar to the changes observed at pH 7.4. However, the
increases in [Ca2]i evoked by 1 mol/L PAR-2-AP and 0.1
mol/L trypsin were significantly lower at pH 6.8 com-
pared with either pH 7.4 or 8.0 (Supplementary Figure 3).
Luminal Exposure to PAR-2-AP and Trypsin
Evokes Intracellular Alkalosis in PDECs
Figure 3 shows pHi recordings from microperfused
pancreatic ducts. Luminal application of the CFTR inhib-
itor (CFTRinh) 172 (10 mol/L) and the anion exchanger
inhibitor H2DIDS (500 mol/L) induced intracellular al-
kalization in PDECs (Figure 3A [i]). These data indicate
that when bicarbonate efflux across the luminal mem-
brane of PDECs (ie, bicarbonate secretion) is blocked,
elevation of duct cell pHi occurs, presumably because the
basolateral transporters continue to move bicarbonate
ions into the duct cell. Note also that the increase in pHi
evoked by the inhibitors is not sustained and begins to
reverse before the inhibitors are withdrawn (Figure 3A [i]),
which might be explained by the regulation of pHi by
basolateral acid/base transporters.
Both luminal PAR-2-AP and trypsin induced a dose-depen-
dent elevation of pHi (Figure 3A [ii and iii]), suggesting that
activation of PAR-2 inhibits bicarbonate efflux across the apical
membrane of the duct cell. Preincubation of PDECswith either
10 mol/L PAR-2-ANT or 5 mol/L SBTI or 40 mol/L
BAPTA-AM for 30 minutes totally blocked the effect of trypsin
on pHi (Figure 3A [iv]). The inhibitory effect of the calcium
chelator BAPTA-AM suggests that the actions of trypsin and
PAR-2-AP on pHi are mediated by the increase in [Ca2]i that
they evoke (Figure 2). Therefore, in this case, the transient
nature of the pHi response may reflect the transient effect that
PAR-2 activators have on [Ca2]i (Figure 2B and E), as well as
pHi regulation by basolateral acid/base transporters.
Next we tested the effects of trypsin on pHi in Cl-free
conditions and during pharmacologic inhibition of the
Figure 2. Effects of PAR-2-AP and trypsin on [Ca2]i in microperfused guinea pig pancreatic ducts at pH 7.4. (A) Light (1) and fluorescent ratio
images (2 and 3) of microperfused pancreatic ducts showing the effects of luminal administration of 10 mol/L PAR-2-AP, 10 mol/L PAR-2-ANT,
or 40 mol/L BAPTA-AM on [Ca2]i. Images were taken before (1 and 2) and after (3) exposure of the ducts to PAR-2-AP or trypsin. (B and C)
Representative experimental traces and summary data of the changes in [Ca2]i. (D) The same protocol was used to evaluate the effects of trypsin.
Addition of 5 mol/L SBTI was used to inhibit trypsin activity. (E and F) Representative experimental traces and summary data of the changes in
[Ca2]i. n  5 for all groups. *P  .05 vs 1 mol/L PAR-2-AP or 0.1 mol/L trypsin, respectively. **P  .001 vs 10 mol/L PAR-2-AP or 10 mol/L
trypsin, respectively.
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Figure 3. Effects of PAR-2-AP and trypsin on pHi in microperfused guinea pig pancreatic ducts. (A) Representative pHi traces showing the effects
of luminal administration of different agents in microperfused pancreatic ducts. (i) A total of 10 mol/L CFTRinh-172 and/or 500 mol/L H2DIDS
caused alkalization of pHi. (ii) PAR-2-AP and (iii) trypsin induced a dose-dependent pHi elevation. (iv) Preincubation of ductal cells with 10 mol/L
PAR-2-ANT or 5 mol/L SBTI or 40 mol/L BAPTA-AM totally blocked the alkalization caused by 10 mol/L trypsin. (v) Removal of luminal Cl or
(vi) administration of H2DIDS (500 mol/L) decreased, but did not totally abolish, the effects of 10 mol/L trypsin on pHi. (vii) Pretreatment with 10
mol/L CFTRinh-172 also decreased the effects of trypsin (10mol/L) on pHi. (viii) Simultaneous administration of H2DIDS and CFTRinh-172 strongly
inhibited the effect of 10 mol/L trypsin. (B and C) Summary of the effects of PAR-2-AP and trypsin on changes in pHi. pHmax was calculated from
the experiments shown in A. (D) Effects of Cl-free conditions. Cl-free conditions, H2DIDS, CFTRinh-172, and a combination of the inhibitors all
induced an intracellular alkalosis. Trypsin further increased the alkalinization of pHi, although the effect was markedly reduced when both H2DIDS and
CFTRinh-172 were present. n  4–5 for all groups. (B) *P  .05 vs 0.1 mol/L trypsin; **P  .001 vs 10 mol/L trypsin. (C) *P  .05 vs 0.1 mol/L
PAR-2-AP; **P  .001 vs 10 mol/L PAR-2-AP. (D) *P  .05 vs the respective filled column.
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luminal anion exchangers and/or CFTR (Figure 3A [v–
viii]). Luminal Cl-free conditions increased the pHi of
PDECs, presumably by driving HCO3 influx on the api-
cal anion exchangers (Figure 3A [v]). Note that luminal
administration of trypsin further elevated pHi in Cl-free
conditions (Figure 3A [v]) and also in the presence of
H2DIDS (Figure 3A [vi]) and CFTRinh-172 (Figure 3A
[vii]). However, pretreatment of ducts with a combination
of H2DIDS and CFTRinh-172 markedly reduced the effect
of trypsin on pHi (Figure 3A [viii]).
Figure 3B–D is a summary of the pHi experiments.
Trypsin (Figure 3B) and PAR-2-AP (Figure 3C) both in-
duced statistically significant, dose-dependent increases in
pHi and these effects were blocked by PAR-2-ANT, SBTI,
and BAPTA-AM. Exposure of the ducts to luminal Cl-
free conditions, H2DIDS, CFTRinh-172, or a combination
of the inhibitors also induced an intracellular alkalosis
(Figure 3D). Also shown in Figure 3D is the additional,
statistically significant increase in pHi caused by trypsin in
ducts exposed to Cl-free conditions and the individual
inhibitors. However, when ducts were exposed to both
CFTRinh-172 and H2DIDS simultaneously, the effect of
trypsin on pHi was markedly reduced, although it re-
mained statistically significant (Figure 3D). We interpret
these results as indicating that trypsin inhibits both
Cl-dependent (ie, anion exchanger mediated; revealed
when CFTR is blocked by CFTRinh-172) and Cl-inde-
pendent (ie, CFTR mediated; revealed in Cl-free con-
ditions and when the luminal exchangers are blocked
by H2DIDS) bicarbonate secretory mechanisms in
PDECs. Reduced bicarbonate secretion will lead to a
decrease in intraductal pH.
Trypsin and PAR-2-AP Inhibit CFTR
Exposure of guinea pig PDECs to 5 mol/L fors-
kolin, which elevates intracellular adenosine 3=5=-cyclic
monophosphate levels, increased basal whole cell currents
(Figure 4A–D [i]) from 8.9  2.3 to 91.2  13.5 pA/pF
(Figure 4A–D [ii]) at 60 mV in 78% of cells (38/49). The
forskolin-activated currents were time- and voltage-inde-
pendent, with a near linear I/V relationship and a reversal
potential of 5.15  1.12 mV (Figure 4A–D [iv]). These
biophysical characteristics indicate that the currents are
carried by CFTR.
Exposure of PDECs to 10 mol/L trypsin did not affect
the basal currents; however, administration of either 10
mol/L PAR-2-AP (Figure 4A [iii]) or 10 mol/L trypsin
(Figure 4B [iii]) inhibited forskolin-stimulated CFTR cur-
rents by 51.7%  10.5% and 57.4%  4.0%, respectively. In
both cases, the inhibition was voltage independent and
irreversible. Pretreatment with either SBTI (10 mol/L;
Figure 4C [iii]) or PAR-2-ANT (10 mol/L; Figure 4D [iii])
completely prevented the inhibitory effect of trypsin on
the forskolin-stimulated CFTR currents. Figure 4E is a
summary of these data, which suggest that trypsin inhib-
its CFTR Cl currents by activation of PAR-2.
Autoactivation of Trypsinogen Is pH
Dependent
Trypsinogen can undergo autocatalytic activation
during which trace amounts of trypsin are generated,
which, in turn, can further activate trypsinogen in a self-
amplifying reaction. Human trypsinogens are particularly
prone to autoactivation, and mutations that facilitate
autoactivation are associated with hereditary pancreatitis.
To assess the effect of a decrease in intraductal pH (caused
by reduced bicarbonate secretion) on trypsinogen activa-
tion, we measured autoactivation of human cationic
trypsinogen in vitro at pH values ranging from 6.0 to 8.5
using a mixture of various buffers. As shown in Figure 5A,
the rate at which cationic trypsinogen autoactivates was
markedly increased as the pH was reduced from 8.5 to 7.0
when the buffer solution contained 1 mmol/L CaCl2 and
no NaCl. However, a further reduction in pH, from 7.0 to
6.0, had little effect (Figure 5A [i]).
To rule out that the differences observed in autoacti-
vation were due to the different ionic strengths of the
buffers used, we repeated the experiments in the presence
of a higher concentration of sodium (100 mmol/L NaCl,
Figure 5A [ii]) or lower concentration of calcium (0.1
mmol/L CaCl2, Figure 5A [iii]). Although the overall au-
toactivation rates were much slower in the presence of
NaCl, the pH profile of autoactivation was essentially
identical to that observed in the absence of added salt
(Figure 5A [ii]). Also, pH-dependent changes in the auto-
activation of trypsinogen were still detectable when the
experiments were performed using a low calcium buffer
(Figure 5A [iii]).
PAR-2 Is Down-regulated in Patients With
Chronic Pancreatitis
It has been documented that there is activated
trypsin in the pancreatic ductal lumen in chronic pancre-
atitis in humans.25–28 If trypsin activity is elevated in the
duct lumen, PAR-2 down-regulation should occur, which
could be due to either (1) changes in PAR-2 mRNA tran-
scription and/or (2) receptor internalization and translo-
cation to the cytoplasm. Our data show a marked
reduction in membranous PAR-2 protein level but no
significant changes in cytoplasmic PAR-2 protein in
chronic pancreatitis (Figure 5B [i–iv] and C). Furthermore,
PAR-2 mRNA expression was markedly reduced in
chronic pancreatitis (Figure 5D), suggesting that reduced
PAR-2 mRNA transcription may cause PAR-2 down-regu-
lation in chronic pancreatitis.
Luminal Exposure to R122H Mutant Cationic
Trypsin Induces Elevation of [Ca2]i and
Evokes Alkalosis in PDECs
It has been shown that mutations in cationic
trypsinogen increase the risk of chronic pancreatitis, most
likely because of the enhanced autoactivation exhibited
by the mutant trypsinogens.29 Here we tested whether
the commonest mutation in cationic trypsin, R122H, af-
fected the ability of the protease to interact with PAR-2.
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Figure 6A and B shows that 1 m of R122H human
cationic trypsin causes comparable changes in pHi and
[Ca2]i to 0.4 mol/L wild-type bovine trypsin, suggesting
that a trypsin-mediated inhibition of bicarbonate secre-
tion could play a role in the pathogenesis of hereditary as
well as chronic pancreatitis.
Activation of PAR-2 Is Diminished in
PAR-2/ Mice
Finally, we investigated the effects of both PAR-
2-AP and trypsin on PDECs isolated from PAR-2/ and
PAR-2/ mice (Figure 6C–E). First we confirmed using
Figure 4. Effects of trypsin and PAR-2-AP on CFTR Cl currents of guinea pig pancreatic duct cells. Representative fast whole cell current
recordings from PDECs. (A–D) (i) Unstimulated currents, (ii) currents after stimulation with 5 mol/L forskolin, and (iii) currents following 3-minute
exposure to (A) 10mol/L PAR-2-AP, (B) 10 mol/L trypsin, (C) 10 mol/L trypsin/5 mol/L SBTI, and (D) 10 mol/L trypsin/10 mol/L PAR-2-ANT.
(iv) I/V relationships. Diamonds represent unstimulated currents, squares represent forskolin-stimulated currents, and triangles represent forskolin-
stimulated currents in the presence of the tested agents (see previous text). (E) Summary of the current density (pA/pF) data obtained from A–D
measured at Erev 60 mV. Exposing PDECs to either PAR-2-AP or trypsin blocked the forskolin-stimulated CFTR Cl currents, while administration
of SBTI or PAR-2-ANT prevented the inhibitory effect of trypsin. n 6 for all groups. *P .05 vs the unstimulated cells, **P .05 vs forskolin. FORSK,
forskolin; TRYP, trypsin.
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immunohistochemistry that PAR-2/ mice do, whereas
PAR-2/ mice do not, express PAR-2 in their PDECs
(Figure 6C [i and iii]). Accordingly, our functional data
clearly show that the pHi and [Ca2]i responses to luminal
administration of either trypsin or PAR-2-AP were mark-
edly diminished in PAR-2/ PDECs (Figure 6D and E).
Discussion
The human pancreatic ductal epithelium secretes 1
to 2 L of alkaline fluid every 24 hours that may contain up
to 140 mmol/L NaHCO3.12,13 The physiologic function of
this alkaline secretion is to wash digestive enzymes down
the ductal tree and into the duodenum and to neutralize
acidic chyme entering the duodenum from the stomach.
There are important lines of evidence supporting the idea
that pancreatic ducts play a role in the pathogenesis of
pancreatitis: (1) ductal fluid and bicarbonate secretion are
compromised in acute and chronic pancreatitis,30,31 (2)
one of the main end points of chronic pancreatitis is the
destruction of the ductal system,32,33 (3) mutations in
CFTR may increase the risk of pancreatitis,30,31,34–36 and
(4) etiologic factors for pancreatitis, such as bile acids or
ethanol in high concentration, inhibit pancreatic ductal
bicarbonate secretion.37–39 Despite the previously men-
Figure 5. The effects of pH on trypsinogen activation and analyses of PAR-2 expression in human pancreatic samples. The autoactivation of human
cationic trypsinogen was determined in vitro at pH values ranging from 6.0 to 8.5. (A) (i) Trypsinogen at 2 mol/L concentration was incubated with
40 nmol/L trypsin at 37oC in 0.1 mol/L Tris  HEPES  2-(N-morpholino)ethanesulfonic acid2-(N-morpholino)ethanesulfonic acid buffer mixture
containing 1 mmol/L CaCl2. (ii) The same protocol was used in high (100 mmol/L) NaCl buffer solution. Autoactivation of cationic trypsinogen
significantly increased as the pH was reduced from 8.5 to 6.0. (iii) The same protocol was used in low (0.1 mmol/L) Ca2-buffered solution buffer
solution. (B) (i–iv) PAR-2 expression. (i) Representative section of normal human pancreas. (ii) No primary antiserum. (iii) Representative section of
human pancreas from a patient with chronic pancreatitis (CP). (iv) No primary antiserum. (C) Relative optical density. n  15. *P  .05 vs CP
membrane. (D) Real-time reverse-transcription polymerase chain reaction analysis of PAR-2 mRNA expression of human pancreas. Data are given
in 2^dCT. n  15. *P  .05 vs CP.
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tioned data, the role of PDECs in the development of
pancreatitis has received relatively little attention.40
There are important species differences regarding the
localization of PAR-2 in pancreatic ducts and in the effect
of its activation on bicarbonate secretion. For example,
CAPAN-1 cells10 and dog PDECs9 express PAR-2 only on
the basolateral membrane, whereas bovine PDECs express
PAR-2 on the luminal membrane.11 Therefore, one of our
Figure 6. Experiments using R122H human
mutant cationic trypsin and PAR-2/ mice.
Representative (A) pHi and (B) [Ca2]i mea-
surements using luminal administration of
normal and R122H mutant cationic trypsin in
microperfused guinea pig pancreatic ducts.
n  5 for all experiments. (C) (i–iv) PAR-2–
expressing cells were visualized by immuno-
histochemistry as described in Figure 1. (i)
Representative section of the pancreas re-
moved from PAR-2/ mice. (ii) Section with-
out primary antiserum. (iii) Pancreas removed
from PAR-2/ mice. (iv) Section without pri-
mary antiserum. (D) pHi and (E) [Ca2]i mea-
surements using luminal administration of
trypsin in microperfused pancreatic ducts
isolated from PAR-2 knockout (red curve)
and PAR-2 wild-type mice (black curve). n 
5 for all experiments. *P  .05 vs 10 mol/L
trypsin PAR-2/, **P  .05 vs 10 mol/L
PAR-2-AP PAR-2/.
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first aims was to determine which animal model best
mimics human PAR-2 expression and thus would be the
best for studying the effects of trypsin on PDEC function.
Our results showed that in the human pancreas PAR-2 is
localized to the luminal membrane of small proximal
pancreatic ducts, which are probably the major site of
bicarbonate and fluid secretion. Because CAPAN-1 cells
and dog PDECs express PAR-2 only on the basolateral
membrane, they do not mimic the human situation. Rats
or mice are also not good models for the human gland
because they secrete only 70 to 80 mmol/L bicarbon-
ate.41,42 However, the guinea pig pancreas secretes 140
mmol/L bicarbonate, as does the human gland, and the
regulation of bicarbonate secretion is similar in both
species.41,42 Because PAR-2 expression in the guinea pig
pancreas was localized to the luminal membrane of duct
cells, we performed our experiments on isolated guinea
pig ducts.
First we characterized the effects of PAR-2 activation by
trypsin and PAR-2-AP on PDECs. Previously, it has been
shown that activation of the G protein–coupled PAR-2 by
proteinases requires proteolytic cleavage of the receptor,
which is followed by an elevation of [Ca2]i.43–45 As ex-
pected, luminal trypsin and PAR2-AP caused a dose-de-
pendent elevation of [Ca2]i in guinea pig ducts. Impor-
tantly, the trypsin inhibitor SBTI, PAR-2-ANT, and the
intracellular calcium chelator BAPTA-AM all completely
blocked the elevation of [Ca2]i, whereas removal of ex-
tracellular Ca2 had no effect. Acidosis (pH 6.8) also
slightly reduced the changes in [Ca2]i evoked by trypsin,
most probably due to reduced cleavage activity of trypsin
at an acidic pH. Next we characterized the effects of PAR-2
activation on pHi. Luminal application of trypsin and
PAR-2-AP both caused a dose-dependent intracellular al-
kalosis in PDECs. This alkalosis is most likely explained
either by a reduction in the rate of bicarbonate efflux (ie,
secretion) across the apical membrane of PDECs or by an
increase in the rate of bicarbonate influx at the basolateral
side of the cell. We favor the former explanation because
luminal application of the anion exchange inhibitor
H2DIDS or the CFTR inhibitor CFTRinh-172 produced a
similar intracellular alkalization.22,46 Thus, PAR-2 activa-
tion inhibits bicarbonate secretion in PDECs by inhibit-
ing SLC26 anion exchangers and CFTR Cl channels
expressed on the apical membrane of the duct cell. In
similarity with the [Ca2]i signals, the effect of PAR-2
activation on pHi was blocked by SBTI, PAR-2-ANT, and
BAPTA-AM, with the action of BAPTA-AM suggesting
that the inhibition of bicarbonate secretion follows from
the increase in [Ca2]i. Interestingly, an elevation of
[Ca2]i is crucial for both stimulatory (eg, acetylcholine,13
low concentrations of bile acids,39 and ethanol38) and
inhibitory pathways (eg, basolateral adenosine triphos-
phate, arginine vasopressin, and high concentrations of
ethanol) that control bicarbonate secretion by PDECs.
Such marked differences in the outcome of [Ca2]i signals
in PDECs probably reflect differences in the source of
Ca2 and/or in the intracellular compartmentalization of
[Ca2]i signals generated by different secretory agonists
and antagonists.
Remarkably, trypsin was still able to evoke an elevation
of pHi when Cl was removed from the duct lumen and
when PDECs were pretreated with H2DIDS, conditions
that should inhibit bicarbonate efflux on the exchanger.
These results suggested the involvement of CFTR, the
only other known bicarbonate efflux pathway on the api-
cal membrane, in the inhibitory effect of trypsin. This
hypothesis was confirmed by patch clamp experiments in
which trypsin decreased CFTR whole cell currents in iso-
lated guinea pig PDECs by 50% to 60%. Finally, the fact
that the trypsin-induced alkalinization was completely
blocked by a combination of CFTRinh-172 and H2DIDS
confirms the involvement of both CFTR and SLC26 anion
exchangers. Our conclusion from these pHi and patch
clamp data is that PAR-2 activation inhibits both the
SLC26 anion exchanger (probably SLC26A6 [PAT-1]47 be-
cause SLC26A3 [DRA] is only weakly inhibited by disul-
fonic stilbenes47,48) and CFTR Cl channels expressed on
the apical membrane of the duct cell.
The pH of pancreatic juice (and therefore the luminal
pH [pHL] in the duct) can vary between approximately 6.8
and 8.0. It has recently been shown that protons core-
leased during exocytosis cause significant acidosis (up to 1
pH unit) in the lumen of the acini.23 However, Ishiguro et
al49 have clearly shown that the pHL in pancreatic ducts is
dependent on the level of bicarbonate secretion. pHL can
be elevated from 7.2 to 8.5 by stimulation with secretin or
forskolin, and this effect was strictly dependent on the
presence of bicarbonate.24,49,50 Also, inhibition of ductal
bicarbonate secretion with H2DIDS can decrease the pHL
to less than 8.0.49 In view of these results, we tested
whether trypsinogen autoactivation was affected by pH
over the range of 6.0 to 8.5. Autoactivation of trypsinogen
was relatively slow at pH 8.5, but decreasing the pH from
8.5 to 7 progressively stimulated autoactivation. These
results suggest that under physiologic conditions bicar-
bonate secretion by PDECs is not only important for
elevating the pH in the duodenum, but also for keeping
pancreatic enzymes in an inactive state in the ductal
system of the gland.
Receptor down-regulation is a phenomenon that occurs
in the continued presence of an agonist and leads to a
reduction in the sensitivity of the cell to the agonist.
Potentially, there are 2 mechanisms that could underlie
receptor down-regulation of PAR-2: (1) after proteolytic
activation, the PAR-2 is internalized by a clathrin-medi-
ated mechanism and then targeted to lysosomes45 and (2)
if trypsin is present for a longer time in the lumen, PAR-2
may be down-regulated at the transcriptional level. In this
study, we provide evidence that the second mechanism,
transcriptional down-regulation, explains the reduced ex-
pression of PAR-2 seen in chronic pancreatitis.
Conflicting data can be found in the literature concern-
ing the role of PAR-2 in acute pancreatitis. Singh et al7
showed that in secretagogue-induced experimental pan-
creatitis, PAR-2 deletion is associated with a more severe
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pancreatitis. Although Laukkarinen et al17 confirmed
these results in cerulein-induced pancreatitis, they also
clearly showed that in taurocholate-induced pancreatitis,
PAR-2 deletion markedly reduced the severity of the dis-
ease. There is no evidence to suggest that clinical pancreatitis
is evoked by supramaximal secretagogue stimulation; how-
ever, the taurocholate-induced pancreatitis model may
mimic the clinical situation. Therefore, Laukkarinen et al17
speculated that PAR-2 activation promotes the worsening of
clinical pancreatitis and our data are consistent with that
hypothesis.
Besides the clear pathophysiologic role of the tryp-
sin/PAR-2 interaction in chronic pancreatitis, there is
still a debate as to why PAR-2 are localized to the
luminal membrane of PDEC in small ducts close to the
acinar cells. What could the physiologic role of this
PAR-2 be? A number of agents have been shown to have
dual effects on PDECs at different concentrations. For
example, bile acids in low concentrations stimulate but
in high concentrations inhibit bicarbonate secretion.39
The same applies to ethanol.38 Under physiologic con-
ditions, trypsin inhibitors are coreleased from acinar
cells with trypsinogen and should block the activity of
any trypsin that is generated spontaneously. Therefore,
only very small amounts of active trypsin, if any, will be
present in the duct lumen under normal conditions.
However, there remains a possibility that very small
amounts of active trypsin (ie, concentrations less than
0.1 mol/L that would not cause an elevation of [Ca2]i
or change in pH) could bind to PAR-2 on the luminal
membrane of the ducts and augment other stimulatory
mechanisms so as to enhance flushing of digestive
enzymes down the ductal tree.
In conclusion, we suggest for the first time that one of
the physiologic roles of bicarbonate secretion by PDECs is
to curtail trypsinogen autoactivation within the pancre-
atic ductal system. However, if trypsin is present in the
duct lumen (as may occur during the early stages of
pancreatitis due to leakage from acinar cells), PAR-2 on
the duct cell will be activated, leading to Ca2 release from
intracellular stores and an increase in cytosolic Ca2 con-
centration. This causes inhibition of the luminal anion
exchangers and CFTR Cl channels, reducing bicarbonate
secretion by the duct cell. The decrease in bicarbonate
secretion will increase the transit time of zymogens down
the duct tree and decrease pHL, both of which will pro-
mote the autoactivation of trypsinogen. The trypsin so
formed will further inhibit bicarbonate transport, leading
to a vicious cycle generating further decreases in pHL and
enhanced trypsinogen activation, which will favor devel-
opment of the pancreatitis (Supplementary Figure 4).
Finally, the R122H mutant cationic trypsin also elevated
[Ca2]i and pHi in duct cells, suggesting that this mech-
anism may be particularly important in hereditary pan-
creatitis in which the mutant trypsinogens more readily
autoactivate.29
Supplementary Material
Note: To access the supplementary material
accompanying this article, visit the online version of
Gastroenterology at www.gastrojournal.org, and at doi:
10.1053/j.gastro.2011.08.039.
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Supplementary Materials and Methods
Ethics
All experiments were conducted in compliance
with the Guide for the Care and Use of Laboratory
Animals (USA NIH publication No 85-23, revised 1985).
Animal experiments were approved by the Regional Eth-
ical Board at the University of Szeged, Hungary.
Solutions and Chemicals
HEPES-buffered solutions were gassed with 100%
O2, and their pH was set to 7.4 with HCl at 37oC. HCO3-
buffered solutions were gassed with 95% O2/5% CO2 to set
pH to 7.4 at 37oC. For patch clamp studies, the standard
extracellular solution contained (in mmol/L): 145 NaCl,
4.5 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 5 glucose (pH
7.4 adjusted with NaOH). The osmolarity of the extra-
cellular solution was 300 mOsm/L. The standard pipette
solution for the patch clamp experiments contained (in
mmol/L): 120 CsCl, 2 MgCl2, 0.2 ethylene glycol-bis(-
aminoethyl ether)-N,N,N=,N=-tetraacetic acid (EGTA), 10
HEPES, and 1 Na2ATP (pH 7.2 adjusted with NaOH).
Chromatographically pure collagenase was purchased
from Worthington (Lakewood, NJ). 2,7-Bis-(2-carboxy-
ethyl)-5-(and-6-)carboxyfluorescein, acetoxymethyl ester
(BCECF-AM), 2-(6-(bis(carboxymethyl)amino)-5-(2-(2-
(bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)-2-
benzofuranyl)-5-oxazolecarboxylic acetoxymethyl ester
(FURA 2-AM), dihydro-4,4=-diisothiocyanostilbene-
2,2=-disulfonic acid (H2DIDS), and 1,2-bis(o-amino-
phenoxy)ethane- N,N,N=,N=-tetraacetic acid (BAPTA-
AM) were from Invitrogen (Carlsbad, CA). PAR-2-ANT
(H-Phe-Ser-Leu-Leu-Arg-Tyr-NH2) and PAR-2-AP (H-
Ser-Leu-Ile-Gly-Arg-Leu-amid trifluoroacetate salt)
were from Peptides International (Louisville, KY). For-
skolin were from Tocris (Ellisville, MO). Rabbit PAR-2
polyclonal antibody was purchased from Santa Cruz
Biotechnology (Heidelberg, Germany). All other chem-
icals were obtained from Sigma-Aldrich (Budapest,
Hungary).
Isolation of Pancreatic Ducts and Individual
Ductal Cells
Male guinea pigs weighing between 150 and 250 g
or mice (PAR-2/ and PAR-2/) weighing between 18
and 21 g were humanely killed by cervical dislocation, the
pancreas was removed, and small intralobular proximal
ducts were isolated by microdissection as described pre-
viously.1 PAR-2/ mice (B6.Cg-F2rl1tm1Mslb/J) were previ-
ously generated by Schmidlin et al1 and a kind gift from
Ashok Saluja.2 Isolated ducts were then cultured over-
night in a 37oC incubator gassed with 5% CO2/95% air.3
To obtain single pancreatic ductal cells, cultured ducts
were incubated for 50 minutes at 37°C in 50 U/mL
elastase dissolved in storage solution (Dulbecco’s modi-
fied Eagle medium containing 3% [wt/vol] bovine serum
albumin [pH 7.4 with NaOH]). Then the ducts were
transferred to a Ca2/Mg2-free HEPES-buffered solu-
tion and incubated for a further 10 minutes at 37°C.
After the incubation, the ducts were transferred to a
coverslip and teased apart using stainless steel needles.
The individual ductal cells were used for experiments
within 3 to 4 hours after isolation.
Measurement of pHi and Ca2 Concentration
Ducts were bathed in standard HEPES solution
and loaded with BCECF-AM (2 mol/L) or FURA 2-AM
(5 mol/L) for 30 to 60 minutes at room temperature.
Ducts were then transferred to a perfusion chamber
mounted on an IX71 inverted microscope (Olympus,
Budapest, Hungary) and perfused continuously with so-
lutions at 37oC both from the luminal and basolateral
side at a rate of 10 to 30 L/min and 4 to 5 mL/min,
respectively. Four to 5 small areas (region of interests) of
5 to 10 cells in each intact duct were excited with light at
a given wavelength. Excitation of BCECF was at 495 and
440 nm, with emitted light monitored at 535 nm. Exci-
tation of FURA-2 was at 380 and 340 nm, with emitted
light monitored at 510 nm. The fluorescence emissions
were captured by a charge-coupled device camera and
digitized by a Cell imaging system (Olympus, Budapest,
Hungary). Ratio images were collected at 1-second inter-
vals. In situ calibration of pHi measured with BCECF was
performed using the high K-nigericin technique.4,5
Electrophysiology
Guinea pig PDECs were isolated by an enzymatic
microdissection procedure as described previously. Using
a glass pipette, a few drops of cell suspension were placed
within a perfusion chamber mounted on the stage of an
inverted microscope (TMS; Nikon, Tokyo, Japan). The
ductal cells were allowed to settle and attach to
the bottom of the chamber for at least 30 minutes before
the perfusion was started.
Patch clamp micropipettes were fabricated from boro-
silicate glass capillaries (Clark, Reading, England) by us-
ing a P-97 Flaming/Brown micropipette puller (Sutter
Co, Novato, CA). These pipettes had resistances between
1.5 and 2.5 M	. Membrane currents were recorded with
an Axopatch 1D amplifier (Axon Instruments, Union
City, CA) using the whole cell configuration of the patch
clamp technique at 37oC. After establishing a high-resis-
tance seal (1–10 G	) by gentle suction, the cell mem-
brane beneath the tip of the pipette was disrupted by
suction or by application of short electrical pulses. The
series resistance was typically 4 to 8 M	 before compen-
sation (50%–80%, depending on the voltage protocol).
Current-voltage (I/V) relationships were obtained by
holding Vm at 0 mV and clamping to 100 mV in 20-mV
increments. Membrane currents were digitized by using a
333-kHz analog-to-digital converter (Digidata 1200;
Axon Instruments) under software control (pClamp 6;
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Axon Instruments). Analyses were performed by using
pClamp 6 software after low-pass filtering at 1 kHz.
Expression and Purification of Human
Trypsinogens
Wild-type and R122H mutant human cationic
trypsinogen was expressed in Escherichia coli and purified
by ecotin-affinity chromatography as reported previ-
ously.6
Measuring Autoactivation of Trypsinogen
Autoactivation of trypsinogen was measured at 2
mol/L concentration at 37oC in a polybuffer system
(American Bioanalytical Inc, Natick, MA) containing 100
mmol/L 2-(N-morpholino)ethanesulfonic acid, 100
mmol/L HEPES, and 100 mmol/L Tris in 100 L final
volume. The pH of the Polybuffer was adjusted to given
values with HCl (pH 6.0 and 6.5) or NaOH (pH 7.0, 7.5,
8.0, and 8.5). Reactions also contained 1 mmol/L or 0.1
mmol/L CaCl2 and 100 mmol/L NaCl, as indicated. At
given times, 2-L aliquots were removed and trypsin
activity was determined using the N-CBZ-Gly-Pro-Arg-p-
nitroanilide substrate at 150 mol/L final concentration.
Immunohistochemistry
Pancreatic tissue from 5 guinea pigs, 15 patient
samples without pancreatic disease near neuroendocrine
tumors (average age, 59.5; female/male, 7:8), and 15 pa-
tients (average age, 56.6; female/male, 4:11) who had
chronic pancreatitis (13 alcohol, 2 gallstone) were inves-
tigated. The human samples were obtained with the per-
mission of the Regional Ethical Committee of Semmel-
weis University (#172/2003).
The pancreatic tissues were fixed in 10% neutral buff-
ered formalin for 24 hours, followed by paraffin embed-
ding, and were then cut and stained with H&E to estab-
lish the diagnosis. Paraffin-embedded, 3- to 4-m-thick
sections were used for immunohistochemistry to detect
PAR-2 expression. The slides were treated for 30 minutes
with target retrieval solution (Dako, Glostrup, Denmark)
in a microwave oven, followed by incubation with the
primary rabbit polyclonal antibody (Santa Cruz Biotech-
nology Inc, Heidelberg, Germany) in 1:100 dilution over-
night at 4°C. Signal detection was achieved by using
ImPRESS reagent with secondary anti-rabbit immuno-
globulin G antibody (20 minutes) (Vector Laboratories,
Burlingame, CA). Diaminobenzidine was used to visual-
ize immune complexes, and nuclear counterstaining was
performed with hematoxylin. For negative controls, the
appropriate antibody was omitted and either the anti-
body diluent alone or isotype-matched immunoglobulin
G serum was used. The negative controls exhibited no
signal. Normal skin epithelial cells were used as positive
controls to confirm correct immunohistochemical stain-
ing for PAR-2 (results not shown).
The immunohistochemical reactions were digitalized
with a Mirax MIDI slide scanner (3DHistech Ltd, Buda-
pest, Hungary). Relative optical (RO) density was calcu-
lated using ImageJ program (National Institutes of
Health, Bethesda, MD). Pixel values (PV) were normalized
to erythrocyte density (PVNorm  PVMeasured – PVErythrocyte)
in all sections. RO-Density value was calculated from the
RO-Density log10(255/PVNorm) equation, assuming that
the brightest value in the image equals 255.
Western blot analysis was used to determine the spec-
ificity of the PAR-2 antibody. Proteins were extracted
from fresh-frozen guinea pig (n  3) and human (n  3)
pancreatic tissue stored at 80°C. Isolation was per-
formed by using lysis buffer (20 mmol/L Tris, pH 7.5, 150
mmol/L NaCl, 2 mmol/L EDTA, 1% Triton X-100 con-
taining protease inhibitor complex [Sigma Aldrich Co,
Budapest, Hungary]). Samples (50 mg) were homoge-
nized, followed by centrifugation at 13,200 rpm at 4°C
for 5 minutes. Measurements of protein concentration
were performed using Bradford analysis.7 A total of 30 g
of protein samples were loaded in each lane, run on 10%
sodium dodecyl sulfate/polyacrylamide electrophoresis
at 200 V for 35 minutes, and then transferred to nitro-
cellulose membranes at 100 V, 4°C, for 75 minutes. For
aspecific protein blocking, nonfat dry milk (5%, phos-
phate-buffered saline) was used for 30 minutes. Blots
were incubated with polyclonal PAR-2 rabbit antibody
(1:300; Santa Cruz Biotechnology Inc, Heidelberg, Ger-
many) and anti-GAPDH antibody (1:5000; AbDSerotec,
Kidlington, England) at 4°C overnight. After washing in
0.1% Tris, the secondary antibodies as anti-mouse
GAPDH (1:2000; AbDSerotec, Düsseldorf, Germany) and
horseradish peroxidase–conjugated anti-rabbit antibody
(1:2000, Dako Cytomation, Ghostrup, Denmark) were
applied at room temperature for 90 minutes. Following 3
series of washings in Tris-buffered saline with Tween 20,
signals were visualized by enhanced chemiluminescent
detection.
Real-Time Reverse-Transcription Polymerase
Chain Reaction
RNA extraction. Fifteen formalin-fixed, paraffin-
embedded normal pancreatic tissue samples and 15 sam-
ples of chronic pancreatitis tissue were selected for real-
time reverse-transcription polymerase chain reaction
analysis. Total RNA was isolated from five 5- to 10-m
macrodissected sections (connective tissue excluded) using
RNeasy FFPE Kit (Qiagen, Hilden, Germany) in accordance
with the manufacturer’s instructions. RNA concentrations
were obtained using a NanoDrop Spectrophotometer ND-
1000 (Thermo Fisher Scientific Inc, Waltham, MA).
Reverse transcription of RNA. Complementary
DNA samples were prepared from 1 g total RNA using
a High Capacity RNA-to-cDNA Kit (Applied Biosystems,
Carlsbad, CA) as specified by the manufacturer.
Primer design. Gene-specific primers were de-
signed by AlleleID 6.01 primer design software (Premier
Biosoft International, Palo Alto, CA) for real-time reverse-
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transcription polymerase chain reaction. Isoform speci-
ficity and primer sizes were checked by BioEdit biological
sequence alignment editor software (Tom Hall Ibis Ther-
apeutics, Carlsbad, CA). Primer specificity was checked by
BiSearch software (Hungarian Academy of Sciences, In-
stitute of Enzymology, Budapest, Hungary). Primer spe-
cific amplification degree (58°C) was optimized by gradi-
ent polymerase chain reaction. The used primer sequences
are shown in Supplementary Table 1.
Reverse-transcription polymerase chain reac-
tion. Real-time reverse-transcription polymerase chain
reaction analysis was performed using SYBR Green tech-
nology on an ABI Prism 7000 Sequence Detection System
(Applied Biosystems, Foster City, CA), according to the
manufacturer’s instructions. -actin was used as the in-
ternal control gene. Primer-specific amplification was
controlled by 2% agarose gel electrophoresis, as well as by
melting temperature analysis. The final 20 L reaction
mixture contained Power SYBR Green PCR Master Mix
(Applied Biosystems), 10 pmol/L of forward and reverse
primers, and 100 ng complementary DNA as template.
Amplification conditions were as follows: incubation at
95°C for 10 minutes, followed by 45 cycles at 95°C for 15
seconds, 60°C for 60 seconds, and 72°C for 15 seconds,
with subsequent melting analysis, heating to 95°C for 20
seconds, cooling to 45°C for 10 seconds, and then re-
heating to 95°C.
Statistical Analysis
Data are expressed as means  SEM. Significant
difference between groups was determined by analysis of
variance. Statistical analysis of the immunohistochemical
data was performed using the Mann–Whitney U test.
Probability values of P  .05 were accepted as being
significant.
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Supplementary Figure 1. Effects of PAR-2-AP and trypsin on [Ca2]i in microperfused guinea pig pancreatic ducts at pH 8.0. (A) Light (1) and
fluorescent ratio images (2 and 3) of microperfused pancreatic ducts showing the effects of luminal administration of 10 mol/L PAR-2-AP and 10
mol/L PAR-2-ANT on [Ca2]i at pH 8.0. Images were taken before (1 and 2) and after (3) exposure of the ducts to PAR-2-AP or trypsin. An increase
in [Ca2]i is denoted by a change from a “cold” color (blue) to a “warmer” color (yellow to red); see scale on the right. (B and C) Representative
experimental traces and summary data of the changes in [Ca2]i at pH 8.0. (D) The same protocol was used to evaluate the effects of trypsin. (E and
F) Representative experimental traces and summary data of the changes in [Ca2]i. n 3–4. *P .05 vs 1 mol/L PAR-2-AP or 0.1 mol/L trypsin,
respectively. **P  .001 vs 10 mol/L PAR-2-AP or 10 mol/L trypsin, respectively.
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Supplementary Figure 2. Effects of PAR-2-AP and trypsin on [Ca2]i in microperfused guinea pig pancreatic ducts at pH 6.8. (A) Light (1) and
fluorescent ratio images (2 and 3) of microperfused pancreatic ducts showing the effects of luminal administration of 10 mol/L PAR-2-AP and 10
mol/L PAR-2-ANT on [Ca2]i at pH 6.8. Images were taken before (1 and 2) and after (3) exposure of the ducts to either PAR-2-AP or trypsin. The
colors are described in Supplementary Figure 1; see scale on the right. (B and C) Representative experimental traces and summary data of the
changes in [Ca2]i at pH 6.8. (D) The same protocol was used to evaluate the effects of trypsin. (E and F) Representative experimental traces and
summary data of the changes in [Ca2]i at pH 6.8. n  3–4. *P  .05 vs 1 mol/L PAR-2-AP or 0.1 mol/L trypsin, respectively. **P  .001 vs 10
mol/L PAR-2-AP or 10 mol/L trypsin, respectively.
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Supplementary Figure 3. Summary of the effects of PAR-2-AP and trypsin on [Ca2]i in microperfused guinea pig pancreatic ducts at different
extracellular pH values. (A) The elevation in [Ca2]i evoked by 1 mol/L PAR-2-AP and (B) 0.1 mol/L trypsin at different extracellular pH values (6.8;
7.4; 8.0). n  3–4. *P  .05 vs at pH 6.8.
Supplementary Figure 4. The vicious trypsin cycle. If trypsin is present in the duct lumen, PAR-2 receptors on the duct cell are activated, leading
to Ca2 release from intracellular stores and an increase in cytosolic Ca2 concentration. This causes inhibition of the luminal anion exchangers and
CFTR Cl channels reducing bicarbonate secretion by the duct cell. The decrease in bicarbonate secretion will decrease luminal pH in the duct, which
strongly accelerates the autoactivation of trypsinogen to trypsin. The activated trypsin will further inhibit bicarbonate transport by the duct cells,
leading to a vicious cycle generating further decreases in luminal pH and enhanced trypsinogen activation with the potential for damaging the gland.
The cycle may eventually be broken by the down-regulation of duct cell PAR-2 expression once pancreatitis is established. N, nucleus.
Supplementary Table 1. Nucleotid Sequences of the Primers Used in the Study.
Gene name Primer sequence (5= to 3=)
Product length
(base pairs)
Annealing
temperature (°C)
-actin GTACGCCAACACAGTGCTG (sense) 100 55
CTTCATTGTGCTGGGTGCC (antisense)
PAR-2 GGCACCATCCAAGGAACCAATAG(sense) 128 58
GCAGAAAACTCATCCACAGAAAAGAC (antisense)
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